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Abstract 
In microbiome studies, 16S rRNA sequencing is commonly used to quantify the taxonomic abun- dance of 
a microbial community. The resulting data are counts of amplicons. However, the total count is not 
informative because of the sampling, sample preparation and sequencing processes. These counts are 
used to obtain estimates of the relative abundance of the taxa, which is com- positional with a unit sum 
constraint. Analysis of compositional data requires special statistical treatment to account for the 
intrinsic dependence of the components due to this constraint. Bal- ance, defined as the normalized log 
ratio of the geometric mean of the values for the two groups of components, provides an interesting way 
of studying microbial community structure, where the two groups represent the beneficial and detrimental 
taxa, respectively. Such a balance can be used to quantify dysbiosis of the microbial community that is 
associated with a clinical outcome. However, identification of the outcome-associated balance is 
challenging. We introduce a Bayesian balance- regression and a Markov Chain Monte Carlo (MCMC) 
stochastic search algorithm to identify the compositional balance that is associated with the outcome. 
Specifically, we propose a random walk strategy in MCMC that explores the very large space of all 
possible balance defined from high dimensional compositional vector. Simulation studies suggest that 
the algorithm can identify the bacterial taxa that define the outcome-associated balance with a high 
probability. The effect of the balance on the outcome can be easily inferred from their predictive posterior 
distribution. We apply the proposed methods to two human microbiome studies and identify the balance 
of gut microbiome composition that are associated with body mass index and risk of inflammatory bowel 
disease, respectively. 
Microbial compositional balance can also be used to define a mediator to link treatment or environ- ment 
factor to an outcome. However, for a given study, the balance that mediates the treatment effect on 
outcome is unknown. We propose a Bayesian balance mediation model and a Markov chain Monte Carlo 
(MCMC) method to simultaneously search for such a balance and to make inference on the mediation 
effects based on the predictive posterior distributions. Based on the proposed model, we show that the 
mediation effect can be defined in terms of balance effect on the outcome, balance indicator and the 
effect of treatment on compositional shift. Our simulation results show that the MCMC sampling can 
effectively identify the balance and provide correct estimate of the direct and mediation effects. We apply 
the method to a microbiome study aiming to understand the role of gut microbiome in linking vegan diet 
to several plasma metabolites. Our analysis shows that vegan diet has strong direct effects and the 
compositional balance identified has a weak to moderate effect on these plasma metabolites, however, 
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ABSTRACT




In microbiome studies, 16S rRNA sequencing is commonly used to quantify the taxonomic abun-
dance of a microbial community. The resulting data are counts of amplicons. However, the total 
count is not informative because of the sampling, sample preparation and sequencing processes. 
These counts are used to obtain estimates of the relative abundance of the taxa, which is com-
positional with a unit sum constraint. Analysis of compositional data requires special statistical 
treatment to account for the intrinsic dependence of the components due to this constraint. Bal-
ance, defined as the normalized log ratio of the geometric mean of the values for the two groups of 
components, provides an interesting way of studying microbial community structure, where the two 
groups represent the beneficial and detrimental taxa, r espectively. Such a balance can be used to 
quantify dysbiosis of the microbial community that is associated with a clinical outcome. However, 
identification of the outcome-associated balance is challenging. We introduce a Bayesian balance-
regression and a Markov Chain Monte Carlo (MCMC) stochastic search algorithm to identify the 
compositional balance that is associated with the outcome. Specifically, w e p ropose a  random 
walk strategy in MCMC that explores the very large space of all possible balance defined from 
high dimensional compositional vector. Simulation studies suggest that the algorithm can identify 
the bacterial taxa that define t he outcome-associated balance with a  h igh p robability. The effect 
of the balance on the outcome can be easily inferred from their predictive posterior distribution. 
We apply the proposed methods to two human microbiome studies and identify the balance of gut 
microbiome composition that are associated with body mass index and risk of inflammatory bowel 
disease, respectively.
Microbial compositional balance can also be used to define a mediator to link treatment or environ-
ment factor to an outcome. However, for a given study, the balance that mediates the treatment 
effect on outcome is unknown. We propose a Bayesian balance mediation model and a Markov
iv
chain Monte Carlo (MCMC) method to simultaneously search for such a balance and to make
inference on the mediation effects based on the predictive posterior distributions. Based on the
proposed model, we show that the mediation effect can be defined in terms of balance effect on
the outcome, balance indicator and the effect of treatment on compositional shift. Our simulation
results show that the MCMC sampling can effectively identify the balance and provide correct es-
timate of the direct and mediation effects. We apply the method to a microbiome study aiming to
understand the role of gut microbiome in linking vegan diet to several plasma metabolites. Our
analysis shows that vegan diet has strong direct effects and the compositional balance identified
has a weak to moderate effect on these plasma metabolites, however, the mediation effects of gut
microbiome on these metabolites are very small.
v
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1.1. Microbiota and human health
Microbiota refers to a collection of small organisms that live as a community. In particular, human
microbiota contains all the bacteria, viruses, fungi, archaea in a particular niche on human body,
like skin, oral and respiratory tracks, intestines, to name a few. Those small organisms co-live with
us and are an integral part of our body. The total number of microbes in human body is estimated
to be in the order of 1014, out-numbering the total of human body cells by 10 to 1 (Ley, Peterson,
and Gordon, 2006; Savage, 1977; Whitman, Coleman, and Wiebe, 1998). Such a large number
of microbes contributes to maintaining human body’s normal functions. For example, microbes
participate in nutrient as well as drug metabolism and immunomodulation. The immune system of
a newborn is first trained by the environmental microbiota encountered after birth. On the other
hand, disruption of microbial community can lead to various diseases. For example, Clostridium
difficile infection (CDI) is due to an increase of C.diff, a bacterium that also resides in healthy
person. Therapeutic strategies that specifically target human microbes are under fast development
and have shown great promise.
Gut microbiota, often referred as gut flora, takes up about 70% of all microbes in human (Ley,
Peterson, and Gordon, 2006; Whitman, Coleman, and Wiebe, 1998). The gut microbiota acts as
an extra layer against outside pathogens (Hooper, 2009)and has an indispensable role in process-
ing/generating special metabolites, fermantation of fibers and mucosal immunity (Herbrand et al.,
2008). Diseases that are reported to be associated with gut microbiota include obesity, Crohn’s
disease, Irritable Bowel Syndrome (IBS) (Ley et al., 2005a, 2006), etc. In addition to digestive
system abnormalities, gut mcirobiota has also been reported to be linked to functions of various
organs including brain, known as gut-brain axis (Cryan et al., 2019), liver and pancreas (Sekirov
et al., 2010). Several approaches have been successfully developed to treat gut microbiota-related
diseases. Transplatation of fecal samples from healthy donors is an effective procedure for treating
Clostridium difficile infection (Kassam et al., 2013). It has also been reported that gut microbiota is
essential in immunotherapy of certain cancer types (Vétizou et al., 2015). One interesting aspect
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of gut microbiota is that our food intake can have impact on this community. As such, probiotics or
prebiotics are usually recommended when a patient is taking antibiotics in order to re-establish gut
microbial community and to reduce antibiotic related diarrhea.
1.2. Current sequencing methods in microbiota studies
Traditionally microbiologists culture a particular microbe and then study its properties in a wet lab.
However, the environmental niche where a microbiota community lives might not be culturable in
reality. As a result, microbiologists do not have the capability to culture all the microbes in that en-
vironment. Microbiome, the total genome from a microbiota sample, is an alternative approach to
studying the composition and functions of all microbes from an environmental sample. Microbiome
are usually obtained by sequencing and the resulting sequences are then processed by various
bioinformatic tools. Compared to the traditional wet lab approach, culture-independent sequenc-
ing of microbiome requires less time as it eliminates the time in culturing each microbe. However,
the functional analysis of a microbiota sample can only be inferred from the sequencing results,
whereas the wet-lab approach is better suited to study the functions of different microbes or a col-
lection of them. Despite the indirect information in functional analyses, most microbiota/microbiome
studies are performed using sequencing methods. The resulting data are often call metagenomic
data, reflecting the fact that sequencing results contain genomes from multiple microbes in a given
community.
Two sequencing strategies are often used in microbiome studies, the target sequencing and shot-
gun metagenomic sequencing. The target sequencing approach depends on certain genes or ge-
nomic regions that are conserved among a large number of microbes and yet have small variations
that can differentiate those microbes at different taxonomic levels. For example, 16S ribosomal
RNA (rRNA) gene is a highly conserved gene in bacteria kingdom (Caporaso et al., 2010). It con-
tains several variable regions that can map each bacteria species along the phylogenetic tree. This
is the most frequently used target gene approach in microbiome studies. In order to profile bacteria
in a sample, researchers first amplify this gene using the conserved sequence and then perform
high-throughput sequencing to get the nucleotide information in the variable regions. The sequenc-
ing reads are first clustered into Operational Taxonomic Unit (OTU), which represents species with
97% as the similarity threshold in clustering analysis. The corresponding bacteria for each OTU
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can be compared with reference microbial genome databases (DeSantis et al., 2006; Kim et al.,
2012).
In contrast, the shotgun metagenomic sequencing strategy does not rely on sequencing particular
genes. It collects all the genetic materials in a sample, randomly shred the genomes and send the
entire genome fragments to sequencers. Assigning each sequencing read to a particular bacte-
rial species and calculating its abundance is a great challenge in analyzing shotgun sequencing
data. Because a lot of regions are shared among the species that are close to each other on the
phylogenetic tree, it is not possible to assign all the sequencing reads from these regions to a par-
ticular species. In the last 20 years, many important bioinformatic tools have been developed for
binning these sequencing reads (Morgan, Darling, and Eisen, 2010). Among these, a clad-specific
approach implemented in MetaPhlAn is widely used in microbiome studies (Segata et al., 2012).
In addition to what have been described above, each sequencing strategy has pros and cons related
to the underlying techniques. Target sequencing is usually cheaper, but only provides information
for a certain type of microorganisms. Since only part of the genomes is sequences, as a result, the
functionality of the entire community can not be studies using target sequencing data. Clustering of
reads into OTU data is another potential caveat. The community profile might change if a different
clustering algorithm is applied. Shotgun metagenomic sequencing, on the other hand, provides
opportunities to study the function of microbiota by first assembling sequencing reads into individual
genomes. Similar to target sequencing approach, it requires an extra step before estimating the
abundance of each species. There are multiple computing algorithms to choose from, which can
lead to discrepancies in the community profiles or abundances. Shotgun metagenomic sequencing
can be used in de novo assembly, which often return many metagenome assembled genomes
(MAGs), many of these MAGs represent unknown species.
1.3. Current statistical methods in microbiome studies
Due to different sequencing depths and total number of sequence reads in different samples, the
read counts are often converted into relative abundance vector with a unit sum. The key property of
microbiome data is compositional, meaning that we only obtain relative abundance of each microbe
that sums up to 1 for a given sample. Special treatment should be taken before running hypothesis
testing or building statistical models with such compositional data. John Atchison, a key statistician
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in the field of compositional data analysis, stated that three principles need to be satisfied when
performing compsitional data analysis: scale invariance, permutation invariance, and subcomposi-
tional coherence (Aitchison, 1982). Bearing these principles in mind, new statistical methods have
been developed for microbiome compositional data (Li, 2015).
Another important feature of microbiome compositional data is high dimensionality. Usually, the
number of species is more than the number of samples in a study. It poses further challenges in
statistical analysis of such data. Recent statistical methodology has focused on the compositional
and high-dimensional feature of microbiome data. For example, Rivera-Pinto et al., 2018 pro-
posed to tackle the effect of a subcomposition from the compositional data by best subset selection
(Rivera-Pinto et al., 2018). The resulting single measure is defined as balance. Balance is defined
as a weighted log ratio between two partitions of a compositional vector x = (x1, x2, · · · , xp). Let
z = (z1, z2, . . . , zp) be a p-dimensional indicator vector with three values, 1, −1, and 0, where zi = 1
indicates that the corresponding part in the composition xi is in the numerator of a ratio, zi = −1
indicates the denominator; and zi = 0 indicates the parts that are not a member of the balance. Let
z+, z−, and z0 be non-overlapping sets of indices of the elements in z whose values are 1, −1 and












where m+,m−,m0 denotes the number of indices in z+, z−, z0 respectively. Such a balance mea-
sure provides a scalar summary of the microbial community and can be used to measure commu-
nity dysbiosis.
The focus of this dissertation is develop a Bayesian framework for balance regression and balance
mediation analysis in order to identify the balance indicator vector z and its corresponding balance
Bz that is associated with an outcome or the balance that serves as a mediator in linking treatment
to an outcome. Bayesian approaches are chosen due to their ability of exploring the very large
space of all possible balance measures that can be constructed from a p dimensional compositonal
vector.
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1.4. Organization of dissertation
This thesis is organized as follows. In Chapter 2, we develop a Bayesian balance linear regression
and an efficient MCMC computational method to identify the balance that is associated with an
outcome using stochastic search. In this project, we propose a variable selection algorithm under
the Bayesian linear regression framework. Selecting which microbes composing the outcome-
associated balance is a NP-hard search problem and we resolve it by using stochastic search. We
formulate the search space using an indicator vector with three discrete values that represent the
position of corresponding microbes in the balance. The value of indicator vector then determines
the balance in each sample. We couple the search procedure with a regression model and design
a new proposal distribution for discrete-valued vectors in the stochastic search. To speed up the
convergence, we eliminate the Gibbs step by integrating out the regression coefficients from the
target distributions. The numerical properties of the proposed method are evaluated by simulations.
We apply the balance regression to several real datasets and demonstrate the applicability and
findings of the proposed method.
In Chapter 3, we develop a Bayesian balance regression for binary outcome and extend the pro-
posed stochastic search variable selection method for binary balance regression. Instead of using
logit function, we propose to use probit function in the regression. There are several advantages of
using the probit link function with binary outcome data under the Bayesian framework. In the probit
regression, we augment the microbiome data by introducing a latent continuous outcome variable
for each sample. The sign of the latent variable determines the actual binary value of the outcome.
We then develop a MCMC algorithm by sampling the latent variables along with the search for the
balance indicator vector. Numerical studies and real data applications show promising results of
the proposed method with binary outcomes.
In Chapter 4, we extend balance regression to balance-based causal mediation analysis where
the microbiome composition serves as a mediator. The aim of our proposed method is to find the
effect of a treatment on the microbiome composition that also affects the continuous outcome. In
traditional mediation analysis, the mediator is usually a single variable. For microbiome studies, the
mediator is a compositional vector. The key of our approach is to identify balance in order to reduce
the effects from high-dimensional compositional mediator into a single measure of balance. We
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propose a generative Bayesian mediation model to estimate the mean vector in the treatment and
control groups, as well as the indicator vector for balance. The mediation effect can be calculated by
applying the balance indicator vector to the difference between the posterior means of the additive
logration transformation of the compositions between treatment and control groups. Inference for
the mediation effect can be performed with posterior distributions of the indirect effect.




BAYESIAN LINEAR BALANCE REGRESSION
2.1. Introduction
Advances in sequencing technology have enabled researchers to study microbial communities with-
out having to culture them in the laboratory. Recent large scale microbiome studies have greatly
expanded our knowledge of the role of microbiome in human health and disease. For example,
dysbiosis of the gut microbiome has been linked to Crohn’s disease, cancer and cardiometabolic
syndrome (Halfvarson et al., 2017; Lewis et al., 2015). Microbial community composition from a
sample can be inferred from16S rRNA sequencing, which provides data on read counts that are
assigned to different taxa. However, the total count is not informative because of the sampling,
sample preparation and sequencing processes. These counts are used to obtain estimates of
the relative abundance of the p taxa in the community, which is compositional with a unit sum
constraint. Such data are called compositional data with p parts, which can be summarized as
x = (x1, x2, . . . , xp) ∈ Sp−1, where xi ≥ 0, i = 1, 2, · · · , p,
∑p
i=1 xi = 1 and Sp−1 represents p − 1-
dimensional simplex.
Standard statistical methods cannot be applied directly to microbiome compositional data because
of the dependence among the p parts (Li, 2015). In addition, according to (Aitchison, 1982), the
analysis of compositional data should satisfy two principles: scale invariance and subcompositional
coherence. The former principle implies that the total count or sequencing read count in microbiome
study should be irrelevant in statistical analysis of the microbial composition. Subcompositional
coherence requires that even two microbial communities have different numbers of bacteria, any
associations found among the overlapping taxa should be not affected by other non-overlapping
taxa. This principle is important, since in microbiome studies, researchers rarely identify the same
number of taxa in different studies.
Log-ratio analysis aims to preserve scale invariance and subcompositional coherence in composi-
tional data analysis. Such a transformation is often performed by first choosing a component from






∀i = 2, 3, . . . , p.
However, the choice of the denominator is arbitrary, so this log-ratio transformation is not symmetric
and may yield different results for different choices of the denominator when these log ratios are
used as covariates in regression analysis. Recently, several researchers Lu, Shi, and Li, 2019;
Shi, Zhang, and Li, 2016; Wang and Zhao, 2017 have developed new inference approaches that
alleviate the non-symmetric issue by introducing a constraint on the regression coefficients. Aitchi-
son Aitchson, 2003 also proposed a symmetric log-ratio transformation, called centered log-ratio




∀i = 1, 2, . . . , p,
where g(x) is the geometric mean of all p components. Centered log-ratio transformed composi-
tional data are intrinsically colinear and the resulting matrix is singular, which can lead to problems
in downstream data analysis. Bates and Tibshirani Bates and Tibshirani, 2019 proposed a penal-
ized variable selection procedure for log ratios formed by all pairwise parts in a compositional data.
The total number of log-ratios is however very large.
All the above log-ratio transformations are developed to address the foundation of compositional
data analysis that individual components have no meaning and it is their relationship to other
components that has meaning. In microbiome studies, the community members may exhibit co-
operative or co-exclusive relationship and the entire community maintains a homeostasis (Griffin,
West, and Buckling, 2004; West et al., 2006). Disruptions in relative proportions of certain mi-
crobes can cause perturbed homeostasis and even pathogenesis. For example, the ratio between
Firmicutes and Bacteroidetes is significantly higher in overweight and obese subjects (Castaner
et al., 2018). Thus, it is critical to carry out statistical analysis based on ratios between groups of
taxa, which is more informative than only considering a pair of taxa and is capable of capturing the
dysbiosis of a microbial community in pathogenic status.
Log-ratio of partitions of a composition, termed balance, was first introduced in geology by Egozcue
and Pawlowsky-Glahn (Egozcue and Pawlowsky-Glahn, 2005), and was recently applied to micro-
biome studies with meaningful discoveries (Morton et al., 2017). Balance is defined as a weighted
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log ratio between two partitions of a compositional vector. Let z = (z1, z2, . . . , zp) be a p-dimensional
indicator vector with three values, 1, −1, and 0, where zi = 1 indicates that the corresponding
part in the composition xi is in the numerator of a ratio, zi = −1 indicates the denominator; and
zi = 0 indicates the parts that are not a member of the balance. Let z+, z−, and z0 be non-
overlapping sets of indices of the elements in z whose values are 1, −1 and 0, respectively, and












where m+,m−,m0 denotes the number of indices in z+, z−, z0 respectively. In previous applica-
tions, the value of the indicator vector z is chosen a priori based on a phylogenetic tree or some
other biological knowledge (Morton et al., 2017; Washburne et al., 2017). However, such informa-
tion may be biased or even misleading since the taxonomic positions do not always differentiate
beneficial from detrimental taxa.
One important question in microbiome data analysis is to identify the vector z and the correspond-
ing balance that is associated with a certain outcome variable based on the data collected. Rivera-
Pinto et al. Rivera-Pinto et al., 2018 proposed a forward selection procedure to derive a balance
from microbiome data. Their method adds one ’best’ taxon at a time into the balance based on an
optimization criterium such as the mean square error and stops when a prescribed maximum num-
ber of taxa is achieved or the improvement of the optimization parameter is lower than a threshold.
However, such a search only explores a small subspace of all possible balances and can lead to
sub-optimal results if the optimal model is not visited in the search space. In addition, when p is
large, searching for all possible 3p balance becomes infeasible.
In this paper we propose a Bayesian balance-regression to construct a balance and to model the as-
sociation between the balance and outcome of interest using stochastic search. Unlike the search
method proposed by Rivera-Pinto et al., 2018, we develop a Markov chain Monte Carlo (MCMC)
stochastic search algorithm that is capable to explore the large search space. The final structure
of the balance can be inferred from the marginal posterior probability of each zi or from the most
probable configuration of z when the MCMC algorithm converges. The MCMC algorithm enables
the posterior inference for the regression coefficients conditional on the structure of balance at each
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iteration of the search algorithm. Since the latent vector z and therefore the balance is unknown,
our MCMC algorithm is very different from the standard Bayesian regression (George and McCul-
loch, 1993) where the covariates are known. In our case, besides sampling the model parameters,
we have to sample the latent indicator vector z. In Bayesian variable selection, the covariates
are observed and one samples the covariate-inclusion indicators to select the covariate that are
associated with the response.
In this Chapter we propose a Bayesian treatment, based on the Bayesian regression framework
(George and McCulloch, 1993), to construct a balance and model the association between balance
and outcome of interest using stochastic search. Besides specifications for priors of unknowns
and setting a threshold for marginal posterior inclusion probability for each taxon, our procedure
is fully automatic. Unlike the greedy search proposed by Rivera-Pinto et al., 2018, we design a
proposal that is capable to explore the entire search space and achieve global optimum. Structure
of the balance can be inferred from the marginal posterior inclusion probability or be reported from
the most probable configurations when the search algorithm converges. We propose to perform
posterior inference for the regression coefficients conditional on the structure of balance at each
iteration of the search algorithm. As a result, the inference on regression coefficients are averaged
over the most probable structures of a balance.
2.2. Bayesian linear balance regression
Consider a microbiome study with n i.i.d. samples from a population. Let y = (y1, · · · , yn) be the
vector of a continuous outcome of length n, X = {xij , i = 1, · · · , n, j = 1 · · · , p} be the compo-
sitional matrix with dimension n × p, where p is the number of taxa observed in the samples and
xij is the abundance of the jth taxon in the ith sample estimated from the sequencing counts.
Let z represent the indicator vector that determines the structure of the balance and the resulting
balance Bz as defined in equation (2.1). We can calculate the balance using (2.1) for the entire
sample when z is known. For a given balance configuration z, let Bz be the vector of the balance
values for the n individuals.
Our main interest is to identify a z indicator vector and the corresponding balance that is strongly
associated with the outcome. Let B1z = (1,Bz) be the n× 2 matrix of columns of 1 and the vector
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Bz. For a given balance configuration z, we define the following Bayesian balance-regression
y|z = B1zβz + εz, εz ∼MVN(0, σ2I) (2.2)
where βz = (β0z, β1z)T is the regression coefficients that depend on z. To complete the model, we
assume the following prior distributions for all the unknown parameters, namely βz, σ2, z, in order
to perform a posterior inference. Similar to Bayesian regression, we assume a normal-inverse-
gamma distribution for βz and σ2 as discussed in George and McCulloch, 1993. More specifically,
we assume that βz = (β0z, β1z)T are jointly normal with mean b0 = (b00, b01)T and covariance
σ2V, where V is a diagonal matrix with entries h, and c. We also assume that σ2 follows an
inverse Gamma distribution with parameters (v/2, vλ/2). The advantage to use a normal-inverse-
gamma prior is that we can obtain a closed form of the marginal distribution y|z after integrating out
βz and σ2. We can therefore sample z with shorter chains and faster convergence, as compared
with other choices of the prior distributions.
The balance configuration vector of z determines the search space and the prior on z represents
our belief of the true structure of a balance. A straightforward choice is an independent multinomial





2 (1− w1 − w2)p−m+−m− , (2.3)
where w1 and w2 are the expected number of variables in z+ and z− group respectively. They affect
the sizes of taxa with positive and negative effects in the posterior inference of the balance. A non-
informative choice is w1 = w2 = 1/3, resulting in f(z) = (1/3)p. On the other hand, small values
of w1 and w2 assume sparse structure of the balance. This prior has implicit assumptions that
the sizes of the sets z+ and z− are approximately equal. It is possible to relax the independence
specification and use a dependent prior among elements of z. If p is large, we suggest to use the
sparse prior for the balance configuration z.
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2.3. Posterior inference based on MCMC
Based on the Bayesian balance-regression model and the respective prior distributions of the pa-








where V∗ = (V−1 + B1zTB1z)−1 and u = V∗(V−1b0 + BT1zy) and βz is integrated out.
We develop the following MCMC algorithm to explore high dimensional sample space of z and to
sample z from its posterior distribution given in (2.4). For stochastic search, three possible value
changes can occur during the random exploration: i) between 0 and 1; ii) between 0 and −1; iii)
between 1 and −1. Modifications between two values has three alterations: value conversions
in either direction and value switch. We set equal probabilities among all possible modifications,
but such probabilities can be adjusted to speed up the exploration of the sampling space. The
convergence and mixing of the MCMC algorithm can be evaluated using different chains witrh
different starting points and by examining the cumulative moving average for each component of z.
After convergence, the posterior inclusion probabilities for the sets z+, z−, z0 are simply taken as
the marginal proportions of 1,−1, 0 in z. A threshold can be set to make inference on which set of
particular taxa should belong to the balance and the resulting balance definition.
Conditioning on z, we can obtain the predictive posterior distribution of the regression coefficients
βz. From model (2.2) and the normal prior distribution of βz, one can show that βz|y, z has a







During each iteration of MCMC, we sample βz from its posterior distribution and perform posterior
inference for βz based on these sampling points. Finally, at the convergence, due to randomness
of z, the posterior samples of βz are averaged over those z, which gives the mean of the predictive
posterior distribution of βz based on model average. Algorithm (1) presents an outline of the final
MCMC agorithm for fitting the balance-regression.
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Algorithm 1: MCMC algorithm for the Bayesian balance-regression analysis
1 sample z|y∗ based on its posterior probability (2.4) and stochastic search.
2 sample βz|y, z from a t-distribution with location parameter u and shape matrix given in (2.5).
3 Obtain posterior probability of Pr(zi|y,X) for balance inference and predictive posterior
distribution of βz.
Since the target distribution of z has two modes when the prior of β1z has a mean value of 0. To
make it identifiable, if the estimate of β1z is less than 0, we flip the signs of z and return a positive
estimate of β1z. This effectively constrains β1z to be positive in order to make z identifiable.
2.4. Numerical studies
2.4.1. Data generation
We evaluate the performance of our proposed method using simulations, For each simulation, we
set n = 100, p = 30, β0 = 1, σ2 = 1 and β1 taking three values 1, 0.5 and 0.1 representing
strong, moderate and small effect of the balance on the outcome. The hyperparameters for prior
distribution of β are chosen as b00 = 0, b01 = 0, c = 106, h = 106, representing uninformative
prior information. For binary outcome, we set c = 103, h = 103 due to the restrictions in Gibbs
sampling of the latent vector y∗ and set w1 and w2 to be 1/3, representing each component being
equally likely to be in the z+, z−, z0 sets. The Inverse Gamma prior distribution IG(v/2, λ/2) corre-
sponds to a likelihood of σ2 that comes from v independent N(0, λ) observations. As a result, v can
be treated as the prior sample size and λ as a prior estimate for σ2. In practice λ can be chosen as
the sample variance of the outcome variable in model (2.2).
To generate the compositions, we first generate n independent vector of dimension p from a mul-
tivariate normal with zero mean, variance of 10 and equicorrelation of 0.2. Taxon count matrix is
generated by exponentiating the above matrix and then taking the greatest integer smaller or equal
to the respective numbers. Zero counts correspond to rare taxa and are replaced with 0.5. Finally
the count matrix is normalized per row and to obtain the compositional matrix X. Across all simula-
tions, the first 3 taxa are in the z+ set of a balance and the next 3 taxa are in z− set. Outcomes are
generated according to model (2.2). The initial values for z are chosen randomly, The performance
of mixing of the Markov chains is evaluated with several starting points.
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2.4.2. Simulation results under uniform prior
Figures 2.1, 2.2,2.3,2.4 summarize the posterior probabilities Pr(zi = 1|y,X), Pr(zi = −1|y,X)
and Pr(zi = 0|y,X) after 105 iterations after 104 burn-ins for all 30 taxa across 100 simulations
under the uniform prior assumption. When the balance effect is strong, the posterior inclusion
probabilities for the first 3 taxa are above 0.75 across all simulations for the compositional taxa in
the z+ set and near 0 for those in the z− group. Similarly, compositional taxa 4 to 6 can be correctly
identified as in the z− set with high probabilities.
When the balance effect becomes weaker, the elements in those two sets can sometimes be iden-
tified with high probabilities. However, the posterior inclusion probabilities are estimated toward the
prior due to a low signal-to-noise ratio as compare to those models with β1z = 1. The remaining
taxa that are not part of the true balance index can sometimes be estimated to have higher posterior








































































































































(f) averaged across simulations
Figure 2.1: Simulation results for balance linear regression model with balance effect β1z = 1
under uniform prior. Pairwise posterior probabilities with all 100 simulations and averaged over 100



























































































































































































































































































































































































































































(f) averaged across simulations
Figure 2.2: Simulation results for balance linear regression model with balance effect β1z = 0.5
under uniform prior. Pairwise posterior probabilities with all 100 simulations and averaged over 100


































































































































































































































































































































































































































































































































































































































































































































































































































































































































(f) averaged across simulations
Figure 2.3: Simulation results for balance linear regression model with balance effect β1z = 0.1
under uniform prior. Pairwise posterior probabilities with all 100 simulations and averaged over 100










































































































































































































































































































































































































































































































































































































































































































































































































































































































































(f) averaged across simulations
Figure 2.4: Simulation results for balance linear regression model with balance effect β1z = 0
under uniform prior. Pairwise posterior probabilities with all 100 simulations and averaged over 100
simulations are plotted for taxa in the positive set z+ (red), negative set z− (blue) and null set z0
(yellow).
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Figure 2.5 shows the posterior mean of β1z over 100 simulations. These boxplots show that they
are centered around the true values. All of the 95% empirical credible intervals derived from the
sampling points contain the true value of β1z, indicating that the MCMC algorithm provides valid
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Figure 2.5: Posterior mean of β1z over 100 simulations in balance linear regression under uniform
prior.
2.4.3. Simulation results under sparse prior
Figures 2.6 ,2.7,2.8 and 2.9 summarize the posterior inclusion probabilities after 105 iterations after
104 burn-ins for all 30 taxa across 100 simulations under the assumption of sparse prior. Similar
to the uniform prior, when the effect size is strong β1z = 1 and medium β1z = 0.5, all taxa can
be correctly identified in the balance. When the effect size is small β1z = 0.1 and null β1z = 0,
averaged posterior probabilities for each taxon are estimated toward the prior and almost all of




























































































(d) averaged across simulations













































(f) averaged across simulations
Figure 2.6: Simulation results for balance linear regression model with balance effect β1z = 1
under sparse prior. Pairwise posterior probabilities with all 100 simulations and averaged over 100
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(d) averaged across simulations




































































































































(f) averaged across simulations
Figure 2.7: Simulation results for balance linear regression model with balance effect β1z = 0.5
under sparse prior. Pairwise posterior probabilities with all 100 simulations and averaged over 100







































































































































































































































































































































































































































































































































































































































































































































































































































(f) averaged across simulations
Figure 2.8: Simulation results for balance linear regression model with balance effect β1z = 0.1
under sparse prior. Pairwise posterior probabilities with all 100 simulations and averaged over 100




























































































































































































































































































































































































































































































































































































































































































































































(f) averaged across simulations
Figure 2.9: Simulation results for balance linear regression model with balance effect β1z = 0
under sparse prior. Pairwise posterior probabilities with all 100 simulations and averaged over 100
simulations are plotted for taxa in the positive set z+ (red), negative set z− (blue) and null set z0
(yellow).
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Figure 2.10 shows the posterior mean of β1z over 100 simulations. These boxplots show that they
are centered around the true values. All of the 95% empirical credible intervals derived from the
sampling points contain the true value of β1z, indicating that the MCMC algorithm provides valid
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Figure 2.10: Posterior mean of β1z over 100 simulations in balance linear regression under sparse
prior.
2.5. Application to two real studies
2.5.1. Association between gut microbiome and BMI - analysis of COMBO Data
Wu et al., 2011 conducted a 16S target sequencing of gut microbiota, aiming to associate the
microbial compositional profiles to diet. In this cross-sectional study, 98 healthy volunteers were
recruited and their fecal samples were collected. Sample DNA were amplified according to the
V1-V2 region in the 16S ribosomal DNA. The operational taxonomic units (OTUs) were grouped
into 87 taxa, which had at least 0.2% relative abundance in one sample and appeared in more than
10% samples. It has been reported previously that microbiome compositions were associated with
obesity (Shi, Zhang, and Li, 2016). We refer this dataset as ’COMBO’ data. In this analysis, we aim
24
to find the balance that is associated with the outcome BMI.
We aggregate the count data into two different taxonomic levels: genus level and phylum level.
Relative abundance is obtained by normalizing the counts. A total of 45 genera and 4 phyla are
identified in the data. The proposed MCMC approach is carried out with the same values of hy-
perparameters as in Section 2.4. We run 5 chains with different starting values to assess the
convergence. Burn-in step is taken to be 104 and total iteration is taken to be 5 × 104. The total
number of iterations is more than necessary for the phylum level data. In practice, 103 is sufficient
for a 4-dimensional z to converge to the posterior distribution. We perform the analysis with both
sparse and uniform search space prior where w1 = w2 = 0.1 and w1 = w2 = 1/3 respectively, to
test the sensitivity of posterior inference from different prior choices.
Analyses of COMBO data at phylum level
Figure 2.11 and Table 2.3 show the analysis results using the phylum level data. A total of 4 phyla
are included in COMBO data so the balance indicator z has a dimension of 4. There are a total of
81 possible values of z and the Markov chain quickly converged. Figure 2.11 shows the posterior
probability for each taxa being in z+, z−, z0 sets. To determine which taxa should be included
in balance, maximum a posteriori (MAP) is used to infer which set of z+, z−, z0 that each taxon
belongs to. In our analysis, we use 0.5 as the threshold to determine which set each taxa belongs
to. Compared to MAP, using 0.5 as a threshold results in fewer taxa in the calculation of balance
index. The reason of using 0.5 threshold instead of MAP is that we require a stronger evidence from
the data to infer the balance index. For phylum level COMBO data, the two criteria lead to the same
inference regarding balance with either the uniform or the sparse prior (Figure 2.11). The balance
is the logratio between Firmicutes and Bacteroidetes. This balance has already been reported
in literature to be associated with diabetee and obesity and the underlying mechanism has been
elucidated through in vivo studies (Backhed et al., 2004; Castaner et al., 2018; Ley et al., 2005b;
























Figure 2.11: Posterior probabilities for each phylum being in each of the z+, z−, z0 sets under
uniform prior (a) and sparse prior (b) for z. Green bar represents the posterior probability in z− set;
Red bar represents the z+ set. The vertical line is the 0.5 cutoff line.
Table 2.1 and Table 2.2 present all the posterior probabilities for phylum level COMBO data analysis
with uniform and sparse prior using 5 different starting points. The posterior probabilities are fairly
consistent using different prior parameters, indicating that our methods are not too sensitive to
choices of the initial values.
Table 2.1: Posterior probabilities with 5 different starting points. Results are for phylum level
COMBO data with uniform prior.
starting 1 starting 2 starting 3 starting 4 starting 5
set z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0
Actinobacteria 0.34 0.35 0.31 0.33 0.35 0.31 0.33 0.35 0.31 0.34 0.35 0.31 0.34 0.35 0.31
Bacteroidetes 0.17 0.59 0.24 0.17 0.60 0.23 0.17 0.59 0.23 0.17 0.60 0.24 0.17 0.59 0.24
Firmicutes 0.78 0.00 0.22 0.78 0.00 0.22 0.79 0.00 0.21 0.79 0.00 0.21 0.79 0.00 0.21
Proteobacteria 0.18 0.40 0.42 0.18 0.39 0.43 0.18 0.39 0.43 0.17 0.39 0.43 0.18 0.40 0.42
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Table 2.2: Posterior probabilities with 5 different starting points. Results are for the phylum level
COMBO data with uniform prior.
starting 1 starting 2 starting 3 starting 4 starting 5
set z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0
Actinobacteria 0.28 0.23 0.50 0.28 0.23 0.50 0.28 0.23 0.50 0.28 0.23 0.50 0.28 0.23 0.49
Bacteroidetes 0.12 0.55 0.33 0.12 0.55 0.33 0.12 0.55 0.33 0.12 0.55 0.33 0.12 0.55 0.33
Firmicutes 0.69 0.00 0.31 0.69 0.00 0.31 0.69 0.00 0.31 0.69 0.00 0.31 0.69 0.00 0.31
Proteobacteria 0.05 0.32 0.63 0.05 0.32 0.63 0.05 0.32 0.63 0.05 0.32 0.63 0.05 0.32 0.63
The scatterplot between BMI and the estimated balance is shown in Figure 2.12, indicating some
association between the balance identified and BMI. The posterior distributions for the regression
coefficients are summarized in Table 2.3, showing similar results using two different priors. This





































































































































































































Figure 2.12: BMI vs the estimated balance in COMBO data. Blue line represents the fitted line from
the linear least squares.
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Table 2.3: Posterior inference for β for phylum level COMBO data set.
Uniform Sparse
mean sd 95% credible interval mean sd 95% credible interval
β0 24.48 2.81 (18.56,30.69) 24.62 2,75 (18.29,30.34)
β1 0.32 0.74 (-0.99,1.99) 0.49 0.82 (-0.99,2.33)
Analyses of the COMBO data at genus level
Figure 2.13, Figure 2.14, Figure 2.15 and Table 2.4 show the analysis results for the genera level
COMBO data. The posterior probability plot under the sparse prior (Figure 2.14) indicate that Aci-
daminococcus, Allisonella have a probability of 0.91 and 0.63 in the z+ set and Alistipes, Clostridium
have a probability of 0.64 and 0.79 in the z− set. Using 0.5 as the threshold, we conclude that un-
der the sparse prior, balance is identified as the normalized log ratio betweenAcidaminococcus,
Allisonella and Alistipes, Clostridium. Acidaminococcus, Allisonella and Clostridium belong to the
Firmicutes phylum and Alistipes belongs to the Bacteroidetes phylum. This finding is consistent
with the previous report that theFirmicutes to Bacteroidetes ratio is associated with diabetes and
obesity.
In comparison, the uniform prior leads to more taxa being identified in the balance index and
fewer taxa with a high posterior probability in the z0 set (Figure 2.13). In particular, Ruminococ-
cus (belongs to Firmicutes), Megasphasera (belongs to Firmicutes), Dorea(belongs to Firmicutes),
Catenibacterium (belongs to Firmicutes) are identified in the numerator of balance index, whereas
Roseburia (belongs to Firmicutes), Oscillibacter (belongs to Firmicutes), Megamonas (belongs to
Firmicutes), Dialister (belongs to Firmicutes), Coprobacillus (belongs to Firmicutes), are identified
as in the denominator, in addition to those taxa found with the sparse prior. Those additional taxa all
belong to Firmicutes, an interesting finding, indicating genera within the same phylum may behave






















































Figure 2.13: Posterior probabilities for each genera in the z+, z−, z0 set under uniform prior for z.
Green bar represents the posterior probability in z− set; Red bar represents the z+ set. The vertical






















































Figure 2.14: Posterior probabilities for each genera in the z+, z−, z0 set under sparse prior for z.
Green bar represents the posterior probability in z− set; Red bar represents the z+ set. The vertical
line is the 0.5 cutoff line.
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Table A.1 and Table A.2 present all the posterior probabilities for genera level data with uniform and
sparse prior for z using 5 different starting values. The posterior probabilities are not sensitive to
the initial values used in the MCMC algorithm.
Figure 2.15 shows the relationship between the outcome BMI and the estimated balance based on
the 0.5 threshold cut and under two different priors for z, indicating the association between the
estimated balance and BMI. Table 2.4 summarizes the posterior distributions of two coefficients.
Consistent with the phylum level data, β1 has a larger posterior mean (2.14) in the sparse prior




































































































































































































Figure 2.15: BMI vs the estimated balance for COMBO genus level data. Blue line represents the
fitted line from the ordinary least squares.
Table 2.4: Posterior inference for β with genera level data in COMBO study
Uniform Sparse
mean sd 95% credible interval mean sd 95% credible interval
β0 25.70 2.88 (19.99,31.41) 26.39 2.99 (20.14,31.89)
β1 1.66 0.53 (0.48,2.63) 2.14 0.55 (1.12,3.28)
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2.5.2. UK twin study
We also apply the proposed method on a dataset collected on twins in the United Kingdom.
Goodrich et al., 2016 conducted a population based microbiome study on a large set of UK twins.
In this study, extensive health data were collected on twins across the country together with gut
microbiome data. The aims of the study include characterizing health status in twins on a popula-
tion base and investigating the genetic/environmental effects or their interactions on general health.
The study enrolled both homozygote and heterozygote twins and some subjects had multiple visits
during the study. Using this data, we are interested in investigating how microbiome changes with
aging. As we do not have direct measures on aging, we use actual age as a proxy outcome.
For our analyses, we first remove subjects whose microbiome data or the sibling’s microbiome data
are missing and remove the bacterial genera that appear in fewer than 20% of the subjects. We
select one twin from each family and randomly divide the dataset into two sets of first twin and
second twin. We call the first dataset ’Twin’ dataset and the second one ’sibling’ dataset, in order
to differentiate the two. Each dataset contains 1224 subjects. A total of 65 genera that belong to 7
phyla are analyzed.
We choose the same values for the hyperparameters as in the COMBO data analyses. Similarly,
we analyze the data under two priors for the balance indicator z: uniform prior and sparse prior on
both the twin and the sibling datasets. We run a total of 3 ∗ 105 iterations and with 5 ∗ 10e burn-in
steps.
Analyses of UK twin data at phylum level
Table 2.5 and Table 2.6 show the posterior probabilies in each of the z+, z−, z0 set for the 7 phyla in
the twin dataset. Five different starting values are used to run the MCMC and the posterior proba-
bilities are similar across those starting values, indicating that the chain has converged. Figure 2.16
plots the posterior probabilities based on the fist set of the initial values.
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Table 2.5: Posterior probabilities with 5 starting points. Results are from phylum level twin data
using uniform prior for z.
starting 1 starting 2 starting 3 starting 4 starting 5
set z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0
Firmicutes 0.94 0.00 0.06 0.94 0.00 0.06 0.94 0.00 0.06 0.94 0.00 0.06 0.94 0.00 0.06
Actinobacteria 0.00 1.00 0.00 0.00 1.00 0.00 0.00 1.00 0.00 0.00 1.00 0.00 0.00 1.00 0.00
Proteobacteria 0.63 0.00 0.37 0.62 0.00 0.38 0.63 0.00 0.37 0.62 0.00 0.37 0.63 0.00 0.37
Verrucomicrobia 0.07 0.00 0.93 0.07 0.00 0.93 0.07 0.00 0.93 0.07 0.00 0.93 0.07 0.00 0.93
Bacteroidetes 0.00 1.00 0.00 0.00 1.00 0.00 0.00 1.00 0.00 0.00 1.00 0.00 0.00 1.00 0.00
Fusobacteria 0.98 0.00 0.02 0.97 0.00 0.03 0.98 0.00 0.02 0.98 0.00 0.02 0.98 0.00 0.02
Euryarchaeota 0.99 0.00 0.01 0.99 0.00 0.01 0.99 0.00 0.01 0.99 0.00 0.01 0.99 0.00 0.01
Table 2.6: Posterior probabilities with 5 starting points. Results are from phylum level twin data
using uniform prior for z.
starting 1 starting 2 starting 3 starting 4 starting 5
set z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0
Firmicutes 0.81 0.00 0.19 0.82 0.00 0.18 0.80 0.00 0.20 0.81 0.00 0.19 0.81 0.00 0.19
Actinobacteria 0.00 0.99 0.01 0.00 1.00 0.00 0.00 0.99 0.01 0.00 0.99 0.01 0.00 0.99 0.01
Proteobacteria 0.26 0.00 0.74 0.25 0.00 0.75 0.25 0.00 0.75 0.24 0.00 0.76 0.26 0.00 0.74
Verrucomicrobia 0.02 0.00 0.98 0.02 0.00 0.98 0.03 0.00 0.97 0.02 0.00 0.98 0.03 0.00 0.97
Bacteroidetes 0.00 0.94 0.06 0.00 0.94 0.06 0.00 0.94 0.06 0.00 0.94 0.06 0.00 0.94 0.06
Fusobacteria 0.89 0.00 0.11 0.89 0.00 0.11 0.88 0.00 0.12 0.88 0.00 0.12 0.89 0.00 0.11
Euryarchaeota 0.93 0.00 0.07 0.92 0.00 0.08 0.92 0.00 0.08 0.92 0.00 0.08 0.92 0.00 0.08
Comparing the uniform prior and the sparse prior for z, and using a 0.5 threshold to declare set
membership, the only difference between these two priors is Proteobacteria. The result is consis-
tent with our belief that under the sparse prior, balance index should contain fewer taxa. With such
a prior belief, our data does not support that Proteobacteria is one of the components in balance
index. We conclude that the balance is composed of the scaled log ratio among Fusoaacteria,




Figure 2.16: Posterior probabilities for individual phylum being in each of the z+, z−, z0 sets for the
UK twin data. Green bar represents the posterior probability in z− set; Red bar represents the z+
set. The vertical line is the 0.5 cutoff line.
Figure 2.17 summarizes the relationship between age and estimated balance using 0.5 as a thresh-
old. A summary of the posterior distribution of β is shown in Table 2.7, indicating the the balance
identified is indeed associated with age. The posterior mean of β is similar under two different pri-
ors, but the variance is larger with the sparse prior indicating the posterior distribution of z is more
flat compared to the uniform prior.
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(a) Uniform Prior (b) Sparse Prior
Figure 2.17: Age vs the estimated balance in UK twin data. Blue line represents the fitted line from
the linear least squares. Magenta line represents the posterior mean of β
Table 2.7: Posterior inference for β with phylum level data in UK twin study
Uniform Sparse
mean sd 95% credible interval mean sd 95% credible interval
β0 66.73 1.39 (63.46,69.22) 66.12 2.82 (56.25,69.62)
β1 1.68 0.24 (1.11,2.23) 1.61 0.39 (0.94,2.62)
Analyses of UK twin data at genus level
Tables A.3 and Table A.4 show the posterior probabilities of a genus being in each of the z+, z−, z0
sets for the 65 genera in the twin dataset. Five different starting points are used to run the MCMC
and the posterior probabilities are similar across those starting points, indicating that the chain has
converged. Figure 2.18 and Figure 2.19 plot the posterior probabilities based on the first set of
initial values. The posterior probabilities for genera are different under uniform and sparse priors.
However, certain genera are consistently identified as being the components of the balance. Given
very large sample space of the latent indicator of 65 dimensions, the sparse prior should be used.
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(a) Uniform Prior
Figure 2.18: Posterior probabilities for individual genus being in each of the z+, z−, z0 sets for the
UK twin data under uniform prior for z. Green bar represents the posterior probability in z− set;
Red bar represents the z+ set. The vertical line is the 0.5 cutoff line.
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(a) Sparse Prior
Figure 2.19: Posterior probabilities for individual genus being in each of the z+, z−, z0 sets for for
the UK twin data under sparse prior for z. Green bar represents the posterior probability in z− set;
Red bar represents the z+ set. The vertical line is the 0.5 cutoff line.
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Figure 2.20 shows the plots of the estimated balance and age under two different priors, indicating
similar trend of association. Table 2.8 shows the posterior mean of β1, which are close under two
different prior assumptions.
(a) Uniform Prior (b) Sparse Prior
Figure 2.20: Age vs the estimated balance for UK twin data at the genus level. Blue line represents
the fitted line from the linear least squares. Magenta line represents the posterior mean of β
Table 2.8: Posterior inference for β under uniform and sparse prior for z for UK twin data at the
genus level.
Uniform Sparse
mean sd 95% credible interval mean sd 95% credible interval
β0 71.97 4.04 (64.14,79.96) 74.83 5.05 (65.2,84.86)
β1 2.50 0.27 (1.98,3.06) 2.67 0.34 (2.05,3.39)
2.6. Discussion
In this Chapter, we have proposed a Bayesian balance-regression and a MCMC stochastic search
algorithm to identify the microbial signature, termed balance, which is related to the outcome of
interest. The balance signature reflects the mutualistic or repellent interactions among microbes.
Balance can be regarded as the extension of the log ratio between two groups of microbes that
are highly indicative of healthy/pathological traits. The proposed method automatically selects the
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most relevant reference taxa in the denominator of the balance, unlike other approaches that adopt
additive log ratio or central log ratio transformation, and at the same time also preserves the scale-
invariance as well as sub-compositional coherence properties. Results from the analysis of the
association between gut microbiome and BMI and IBD demonstrated the model and methods can
indeed identify the balance feature that is closely associated with these outcomes. The balance
can be used as an index for dysbiosis of the microbial community,
The MCMC stochastic search in our method allows feasible exploration of the moderate to high
dimensional space (3p-dimensional for p taxa) whereas the search algorithm Rivera-Pinto et al.,
2018 only searches for a small space of possible balance since it only allows adding one component
to the positive part or the negative part of the previous sets during the iterations. Our algorithm
allows the elements in the previous sets being removed out of the balance set or switching from the
positive set to the negative set or vice versus. Another advantage of using a Bayesian approach
to balance-regression is that it automatically provides an assessment of uncertainty of the balance
identified and its effect on the outcome.
As for any Bayesian methods, one needs to choose sensible values for the hyperparameters in the
prior distributions. In our analysis, we used non-informative or vague priors. However, in studies
where sample size is small or noise level is high, the selection result can be affected by the prior
parameters. During MCMC sampling, we obtain the the posterior inclusion probabilities of all three
sets for each of the taxa. We use the posterior modes to choose the final set of z and the corre-
sponding balance. Since the conditional posterior distribution of βz has a closed form, statistical
inference about βz can be made based on the final estimate of z. In this case, our inference of βz
can be interpreted as conditioning on z. However, in real data analysis, the posterior probabilities in
the three sets might only differ slightly in magnitudes, which makes posterior inference of z difficult.
In this case, the posterior inference about βz can be performed on the sampling points obtained
during each iteration of MCMC in the framework of model average.
Our proposed balance-regression model and the MCMC method are very different from the Bayesian
variable selection in linear models (Holmes and Held, 2006). One key difference is that the covari-
ate (i..e, the balance) in our model (2.2) is unknown and has to be identified. Our models have only
one covariate, but it is not observed. In constrast, the standard Bayesian linear model selection
aims to identify the relevant covariates from a set of fixed covariates. The proposed method aims to
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discover a particular form from a subset of taxa that act as one explanatory entity for the outcome.
In this regard, we treat the regression coefficient as a nuisance parameter and integrate it out of
the target distribution. Whereas in Bayesian variable selection, whether a covariate is in the final
model depends on the associated regression coefficient being zero or not.
Identifying the balance that is associated with an clinical outcome is a challenging problem. Al-
though we have demonstrated through simulations that the MCMC algorithm is effective in identi-
fying the structure of the balance, our results are based on simulating the data from the proposed
models. It would be interesting to further investigate the methods by simulating data from alterna-
tive models such as the compositional linear or generalized linear models studied in Lu, Shi, and
Li, 2019; Shi, Zhang, and Li, 2016 for microbiome studies. In fact, if the balance indicator vector
z is known, the balance-regression model proposed in this paper is a special case of the model in
Shi, Zhang, and Li, 2016, where the positive coefficients of all relevant taxa are assumed to be the
same and the negative coefficients of all relevant taxa are also assumed to be the same.
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CHAPTER 3
BAYESIAN PROBIT BALANCE REGRESSION
3.1. Introduction
Interrogating gut microbiome provides an important tool to understand not only the gastrointestinal
tract related diseases, but also abnormalities in immune system, respiratory system and even in the
brain. How to determine the association between each taxon in the microbiome and the disease
status has been a challenging problem due to both high dimensionality and lack of measurements of
absolute bacterial abundances. The p >> n problem in microbiome data analysis can be mitigated
using high-dimensional statistical methods (Li, 2015; Lu, Shi, and Li, 2019; Shi, Zhang, and Li,
2016), and satisfactory results have been achieved in numerical simulations as well as in real data
analysis. To reduce the complexity in interpretation of results and to provide an intuitive yet accurate
inference, a simplified summary of microbiome compositional data is necessary.
Finding simple summary of microbiome compositional data that is biologically relevant is to some
extent equivalent to dimension reduction in statistics, In the most extreme case, we can combine
all the dimensions and summarize them into one number. Due to the skewness of microbiome
compositional data, a geometric mean is more appropriate than a simple average. However, the
geometric mean tells us nothing about the relationship among different taxa. In healthy human,
although its composition might be different, the microbiota community roughly maintains a home-
ostasis and is resistant to slight or moderate perturbations (Das and Nair, 2019). Dysbiosis, though
not fully characterized, is often associated with various disease. Thus it is important to simplify the
microbiome data with a number that can capture the interplay within the microbiota.
As microbiome data is compositional, three principles, namely permutation invariance, scale invari-
ance and subcompositional cohesion must be satisfied (Aitchson, 2003). With this regard, a log
ratio transformation is a natural choice to transform the compositional data (Aitchson, 2003). The
concept of balance introduced by Rivera-Pinto et al., 2018 is a useful index to characterize the mi-
crobiome data with a single scalar, which meets the three principles and also captures the relation-
ship within the microbiota. The balance defined as in equation (2.1) in Chapter 2, can be regarded
as a weighted log ratio between two partitions of a compositional vector, say x = (x1, x2, · · · , xp).
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Let z = (z1, z2, . . . , zp) be a p-dimensional indicator vector with three values, 1, −1, and 0, where
zi = 1 indicates that the corresponding part in the composition xi is in the numerator of a ratio,
zi = −1 indicates the denominator; and zi = 0 indicates the parts that are not a member of the
balance. Let z+, z−, and z0 be non-overlapping sets of indices of the elements in z whose values
are 1, −1 and 0, respectively, and z+ ∪ z− ∪ z0 = {1, 2, . . . , p}. Given z, the corresponding balance












where m+,m−,m0 denotes the number of indices in z+, z−, z0 respectively.
In this chapter, we extend Bayesian linear Balance regression in Chapter 2 to the binary outcomes
such as disease status. In Bayesian literature, a popular method for modeling a binary outcome
is to use auxiliary continuous outcome variable (Albert and Chib, 1993; Holmes and Held, 2006)
that can be modeled with a linear model. The final binary outcome is determined by the sign of
this auxiliary variable. This setup leads to closed-form expressions of posterior distribution and
conditional distributions. Mathematically, it corresponds to a generalized linear model with probit
link and computationally such a setup makes the sampling procedure faster (Holmes and Held,
2006)
3.2. Bayesian balance probit regression
For a binary outcome, let yi be the outcome for subject i that takes only two possible values 0 and
1 and xi be the p-dimensional compositional vector of p bacterial relative abundances. Similar to
model (2.2), we define B1z = (1,Bz) to be the n × 2 matrix with columns of 1 and the vector Bz,
where z is the indicator vector that defines the balance and Bzi is defined as in equation (3.1). The
following model with a hidden variable y∗i corresponds to the generalized linear model with a probit
link (Holmes and Held, 2006),
yi =




y∗i |z = β0z + β1zBzi + εiz
εiz ∼ N(0, 1)
(3.2)
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The prior distribution for βz = (β0z, β1z) is chosen as the multivariate normal with mean b0 and
diagonal covariance matrix Σ, whose entries are v0, v1. After integrating out β, the conditional










with Σ∗ = (I + B1zΣB1zT )−1, and g(y|y∗) is an indicator function which truncates the multivariate
normal distribution of y∗ to the appropriate region. Therefore y∗|y, z simply follows a truncated
normal distribution with truncation at zero. Sampling from this distribution is achieved by Gibbs
sampling the multivariate truncated normal distribution, y∗i |y∗−i, yi, z, where y∗−i denotes the auxiliary
variable y∗ with the ith variable removed. This is a univariate truncated normal distribution with the
mean and variance that can be obtained from the leave-one-out marginal predictive density derived
from (3.3).
The posterior distribution of z is proportional to multiplying equation (3.3) by the prior of z given
in equation (2.3). Due to unobserved y∗, we need to sample both z and y∗ in our algorithm. The
information from the observed data y is used to infer y∗, which in turn determines z. As a result we
propose the following MCMC sampling steps (see Algorithm 2).
Algorithm 2: MCMC algorithm for the Bayesian probit balance-regression analysis
1 sample y∗|y, z from truncated normal whose original form is equation (3.3) and truncation
occurs at 0. This is achieved by Gibbs sampling based on the density of (3.3).
2 sample z|y∗. This step is equivalent to the sampling in Chapter 2
3 return to the first step until convergence.
The posterior inference of the balance structure is the same as the Bayesian linear balance regres-
sion studied in Chapter 2. Here, we propose to carry out the predictive posterior inference for βz
conditional on y∗, z, as the information contained in y is passed onto y∗. In each MCMC iteration,
given z and y∗, the posterior distribution of βz is a multivariate normal with mean vector µ̃ and
variance covariance matrix Σ̃ given as
µ̃ = Σ̃(BT1zy
∗ + Σ−1b0),
Σ̃ = (Σ−1 + BT1zB1z)
−1.
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From this, we can obtain the mean of the predictive posterior distribution of βz given z.
3.3. Numerical studies
The performance of Bayesian balance probit regression is evaluated with simulations. The hyper-
parameters in prior distributions are chosen to be uninformative or a flat prior, allowing data to take
more weights in the posterior distributions. The values of the hyperparameters are summarized as
the following: b00 = 0, b01 = 0, v0 = 103, v1 = 103, w1 = w2 = 1/3. These choices of the hyperpa-
rameters represent noninformative priors, giving the data a better chance to influence the posterior.
For binary outcome, we set c = 103, h = 103 due to the restrictions in Gibbs sampling of the latent
vector y∗. The probabilities for each taxon being in the z+, z−, z0 are assumed to be equal. We set
v = 3, λ = 1, corresponding to a prior estimate for σ2 being 1. In practice, λ can be chosen as the
sample variance of the outcomes, leading to an empirical prior.
For all the simulations, we use n = 100, p = 30, β0 = 1, σ2 = 1. The balance is composed of
the first three taxa in the z+ set and the next three in the z− set, all the rest are in the z0 set. We
evaluate strong, moderate, small and null effect size of β1z, namely 1, 0.5, 0.1 and 0. To generate
the compositions, we first generate n independent vector of dimension p from a multivariate normal
distribution with zero mean vector and covariance of first order auto-correlation. The correlation pa-
rameter is set to 0.2 and the variance equals 10. The taxa count matrix is created by exponentiating
and then applying the floor function to get the greatest smaller integer. Zero counts are replaced
with 0.5 and the count matrix is normalized per row and log-transformed to get X. The y∗,y are
generated according to balance probit regression model (3.2). Starting values for z is random. The
mixing property of Markov chains are evaluated with several starting values of z.
3.3.1. Results under uniform prior of z
Compared to Bayesian linear balance regression, the posterior probability in the probit regression
(Figures 3.1,3.2,3.3, 3.4) tends to shrink to the prior with greater degrees. The extra randomness
caused by sampling the latent vector y∗ has greater effects on the posterior inference for z. Similar
to the linear regression and as expected, stronger balance effect has a better chance of identifying
the correct structure of the balance. In the worst case of weak or null effect, where β = 0.1 or





































































































































































































































































































































































































































































































































































































(f) averaged across simulations
Figure 3.1: Simulation results for balance probit regression model with balance effect β1z = 1 under
uniform prior for z. Pairwise posterior probabilities with all 100 simulations and averaged over 100




































































































































































































































































































































































































































































































































































































(f) averaged across simulations
Figure 3.2: Simulation results for balance probit regression model with balance effect β1z = 0.5
under uniform prior for z. Pairwise posterior probabilities with all 100 simulations and averaged







































































































































































































































































































































































(f) averaged across simulations
Figure 3.3: Simulation results for balance probit regression model with balance effect β1z = 0.1
under uniform prior for z. Pairwise posterior probabilities with all 100 simulations and averaged




































































































































































































































































































































































(f) averaged across simulations
Figure 3.4: Simulation results for balance probit regression model with balance effect β1z = 0 under
uniform prior for z. Pairwise posterior probabilities with all 100 simulations and averaged over 100
simulations are plotted for taxa in the positive set z+ (red), negative set z− (blue) and null set z0
(yellow).
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3.3.2. Results under sparse prior of z
Figures 3.5, 3.6,3.7 and Figure 3.8 summarize the posterior probabilities under sparse prior all
30 covariates across 100 simulations. Similar to the uniform prior, when the effect size is strong
β1z = 1 and medium β1z = 0.5, all taxa can be correctly identified in the balance structure. When
the effect size is small β1z = 0.1 and none β1z = 0, averaged posterior probabilities for each taxon
shrink toward the prior and almost all of them are identified in the z0 set. Compared to uniform prior,
all the simulation points are more dispersed. With a sparse prior the shrinkage effect toward the
prior distribution is even more severe in the first six components where the true value is in the z+
or z− sets. With a small effect size β = 0.1, almost all components have a high posterior probability
of being in the z0 set. These results show that for the Bayesian probit balance regression, taking
























































































































































































































































































































(d) averaged across simulations
























































































































































(f) averaged across simulations
Figure 3.5: Simulation results for balance probit regression model with balance effect β1z = 1 under
sparse prior for z. Pairwise posterior probabilities with all 100 simulations and averaged over 100









































































































































































































































































































































































































































































































(f) averaged across simulations
Figure 3.6: Simulation results for balance probit regression model with balance effect β1z = 0.5
under sparse prior for z. Pairwise posterior probabilities with all 100 simulations and averaged over































































































































































































































































(f) averaged across simulations
Figure 3.7: Simulation results for balance probit regression model with balance effect β1z = 0.1
under sparse prior for z. Pairwise posterior probabilities with all 100 simulations and averaged over
























































































































































































































































(f) averaged across simulations
Figure 3.8: Simulation results for balance probit regression model with balance effect β1z = 0 under
sparse prior for z. Pairwise posterior probabilities with all 100 simulations and averaged over 100
simulations are plotted for taxa in the positive set z+ (red), negative set z− (blue) and null set z0
(yellow).
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3.3.3. Posterior distribution of β1z
Figure 3.9 and Figure 3.10 show the posterior mean of β1z over 100 simulations under uniform
and sparse prior, respectively. Compared to Figure 2.5 and Figure 2.10 in Bayesian linear balance
regression, the posterior estimates of β1z tends to shrink to null, resulting in biased estimates from
the posterior means. This is largely due to the randomness introduced during sampling of the
unobserved latent vector y∗. The posterior mean based on sampling β1z|y∗, z suffers from a larger
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(b) Conditional on y,z
Figure 3.9: Posterior mean of β1z over 100 simulations in Bayesian probit balance regression under
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(b) Conditional on y,z
Figure 3.10: Posterior mean of β1z over 100 simulations in Bayesian probit balance regression
under the sparse prior for z.
3.4. Application to real data analysis
Crohn’s disease is one type of inflammatory bowel disease (IBD). Lewis et al., 2015 at University
of Pennsylvania performed a study to examine the effect of inflammation, diet and antibiotic on the
composition of gut microbiome. For this study, stool samples from 85 pediatric patients with Crohn’s
disease and 26 healthy volunteers were sequenced using shotgun metagenomic sequencing prior
to any treatment or intervention. After quality control and filtering of rare taxa, 39 genera were
obtained and their relative abundances were quantified. Low abundance genera with 0 values in
more than 80% of all subjects were removed, resulting in 31 genera for our analysis. Zero values
were replaced with half of the minimum abundance observed, a common practice in microbiome
studies (Cao, Lin, and Li, 2017; Kurtz et al., 2015) and the proportions were recalculated after such
zero replacements. We refer to this dataset as the IBD data set.
We use the same hyperparameter values as in Section 3.3 to perform proposed MCMC algorithm
for the IBD data set. Five different starting values are randomly selected to check the convergence
of Markov chains. Total number of iteration is 3× 105 and burn-in is taken as the first 105 iterations.
We also perform a sensitivity analysis with a non-informative and a sparse prior for the model space.
Similar to Chapter 2, we also aggregate the data into two taxonomic levels: phylum level and genus
level.
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3.4.1. Analyses of the IBD data at the phylum level
With phylum level data, the total number of iterations is set to 105 and the burn-in step is 104. The
posterior probabilities of each phylum being in the z+, z−, z0 sets differ a little bit with two different
priors, where the posterior probability being in z+ or z− for each phylum is lower under the sparse
prior (see Table 3.1 and Table 3.2). Using 0.5 as the threshold for inference, the two priors agree on
the bacteria that define the balance index, which is composed of log ratio of the relative abundance

























Figure 3.11: Analysis of IBD data set at the phylum level. Posterior probability for 5 bacteria phyla
being in the z+, z−, z0 sets are shown. Top plot (a): uniform prior; bottom plot (b): sparse prior.
Table 3.1: Posterior probabilities with 5 starting points. Results are for genus level IBD data with
uniform prior for z.
starting 1 starting 2 starting 3 starting 4 starting 5
set z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0
Bacteroidetes 0.09 0.46 0.44 0.09 0.46 0.45 0.10 0.47 0.44 0.10 0.46 0.44 0.10 0.46 0.44
Firmicutes 0.39 0.17 0.43 0.39 0.17 0.44 0.40 0.17 0.43 0.38 0.18 0.44 0.40 0.18 0.43
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Table 3.1: Posterior probabilities with 5 starting points. Results are for genus level IBD data with
uniform prior for z.
starting 1 starting 2 starting 3 starting 4 starting 5
set z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0
Verrucomicrobia 0.01 0.89 0.10 0.01 0.89 0.10 0.01 0.89 0.10 0.01 0.89 0.10 0.01 0.89 0.11
Proteobacteria 0.89 0.01 0.10 0.88 0.01 0.11 0.89 0.01 0.10 0.89 0.01 0.10 0.88 0.01 0.11
Actinobacteria 0.29 0.17 0.54 0.28 0.17 0.55 0.29 0.18 0.53 0.28 0.17 0.55 0.28 0.18 0.54
Table 3.2: Posterior probabilities with 5 starting points. Results are for genus level IBD data with
sparse prior for z.
starting 1 starting 2 starting 3 starting 4 starting 5
set z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0
Bacteroidetes 0.05 0.26 0.69 0.04 0.25 0.71 0.04 0.25 0.71 0.05 0.26 0.70 0.04 0.24 0.72
Firmicutes 0.23 0.09 0.68 0.22 0.09 0.69 0.23 0.08 0.69 0.22 0.09 0.69 0.23 0.08 0.69
Verrucomicrobia 0.00 0.84 0.16 0.00 0.83 0.17 0.00 0.84 0.16 0.00 0.84 0.16 0.00 0.84 0.16
Proteobacteria 0.82 0.00 0.17 0.82 0.00 0.18 0.82 0.00 0.18 0.83 0.00 0.17 0.81 0.00 0.18
Actinobacteria 0.14 0.07 0.79 0.14 0.07 0.79 0.14 0.06 0.80 0.14 0.07 0.79 0.14 0.07 0.79
Summary of the posterior distributions of β under both the uniform and sparse priors is shown in
Table 3.3. The posterior distribution of β is not sensitive to the choice of model space priors, both
showing that the balance identified is associated with the risk of IBD.
Table 3.3: Posterior distribution of β with phylum level data in IBD study. The posterior mean is
calculated conditioning on y, z
Conditional mean based on y, z
Non-informative prior Sparse prior
β0 β1 β0 β1
Mean(sd) 0.32(0.41) 0.16(0.04) 0.29(0.43) 0.15(0.03)
95% credible interval (-0.24,1.20) (0.08,0.21) (-0.26,1.20) (0.08,0.20)
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3.4.2. Analysis of the IBD data at genus level
Analysis using the genus level data is computed with 3 × 105 iteration and 5 × 104 burn-in steps.
Analysis results are shown in Figure 3.12,Figure 3.13, Table A.5,Table A.6 and Figure 3.14.
The posterior probabilities of each genus being in the z+, z−, z0 sets differ for two different priors.
This is largely due to small sample size and a large number of bacterial taxa in the model. For
the uniform prior, where we believe the each taxon is equally likely to be in one of the three sets
(Figure 3.12), using 0.5 as the threshold for posterior inference, we conclude from Figure 3.12
that Veillonella (Firmicutes), Rothia (Actinobacteria), Klebsiella (Proteobacteria), Escherichia (Pro-
teobacteria), Eggerthella (Actinobacteria) belong to the z+ set and Roseburia (Firmicutes), Pre-
votella (Bacteroidetes), Odoribacter (Bacteroidetes), Akkermansia (Verrucomicrobia) belong to the
z− set. As a comparison, using the sparse prior (Figure 3.13), Escherichia (Proteobacteria) is in

















































































Figure 3.13: Posterior probabilities for 31 bacterial genera being in the z+, z−, z0 sets under the
sparse prior assumption.
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Table 3.4: Posterior distribution of β for the IBD data at the genus level. The posterior mean is
calculated conditioning on y, z.
Conditional mean based on y, z
Non-informative prior Sparse prior
β0 β1 β0 β1
Mean(sd) 1.43(0.70) 0.26(0.06) 1.16(0.61) 0.26(0.06)
95% credible interval (0.22,2.95) (0.15,0.38) (0.18,2.61) (0.16,0.38)
Table 3.4 shows a summary of the posterior distribution of the balance effect, indicating the asso-
ciation between the identified balance and the risk of IBD. The balance identified and our results
are in general consistent with other finding in literature. We show that microbiota dysbiosis in IBD
is characterized by an increase in Proteobacteria and a decrease in Firmicutes Lewis et al., 2015.
In addition, our results also suggest other bacteria, especially Actinobacteria, Bacteroidetes and
Verrucomicrobia might also be involved in the dysbiosis related to IBD.
Figure 3.14 shows the relationship between the IBD status and the estimated balance for models
with uniform prior and sparse prior. In general, we observe that the estimated balance indeed






















Figure 3.14: Scatter plot of IBD status vs the estimated balance with using genus level data in IBD
study using (a) uniform prior and (b) sparse prior for z. Solid line is estimated line from generalized
linear model with probit link.
3.5. Discussion
The proposed Bayesian probit balance regression provides a method to discover the association
between balance, a scalar that summarizes the microbiome compositional data, and the disease
status, accounting for the potential interactions within microbiota. In this work, we extend the
Bayesian linear balance regression in order to find the balance indicator that is associated with
a binary outcome. Using the probit link with an auxiliary latent response variable facilitates the pos-
terior sampling of the parameters, since the posterior and conditional distributions can be derived
with closed-form expressions. Under this model, the data generation process can be partitioned
into two steps. First, the balance index contributes to a continuous auxiliary response variable
through a link function, and then the sign of the latent outcome determines the observed binary
value. An efficient MCMC sampling algorithm is proposed and implemented. Numerical studies
have proved its usefulness and illustrated the model performance. We have also applied the model
to a real data set and identified a simple bacterial balance that is associated IBD.
In Bayesian probit balance regression, since there are no conjugate priors for the regression coeffi-
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cients, the computation is more challenging and time-consuming. The probit link we used is a more
natural extension of continuous outcome regression to binary outcome. Due to the extra sampling
step for the auxiliary latent variable y∗, it is more difficult to obtain accurate posterior inference in
regression parameters for our proposed models. Compared to the Bayesian balance linear model
with the same true parameter values, the posterior probabilities of the balance indicator in each
of the z+, z−, z0 tend to shrink more toward the prior means that are equal among all three sets.
For our simulations, the truncated multivariate normal distribution for the latent variable y∗ has a
dimensionality of n = 100, which can be very time consuming to sample. In our implementation, a
Gibbs sampling is used to sample one coordinate at a time. With such a high dimension, it took a
long time to find a single point in the truncated space, and even longer time to find a good point in
such a truncated space. We have tried different sample sizes, and n = 100 is the maximum sample
size that we can manage to complete the simulation studies.
Alternatively, one can develop Bayesian logistic balance regression, in which case Laplacian ap-
proximation of the posterior can be applied. Such an approximation does not limit what link function
to use in the regression, but it might lead to reduced accuracy because it relies on a linearization of
the posterior function. After approximation, a multivariate normal priors can be imposed to obtain
a closed-form posterior distribution of the model. An future research topic is to use the Laplacian
approximation and the logistic link for logistic balance regression analysis.
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CHAPTER 4
BAYESIAN BALANCE MEDIATION ANALYSIS
4.1. Introduction
Microbiome, the totality of all the microbes on and in human body, has been shown to be associ-
ated with human health and disease. Those microbes exert their functions in a coordinated fashion
and their abundance relative to each other is relatively stable from day to day. However, dysbiosis,
defined as large fluctuations in the relative abundance of the microbes can lead to disease. For
example, Clostridium difficile infection is a potentially lethal disease in the large intestine that is
caused by the toxic spores from excessive proliferation of Clostridium difficile bacteria. Although
Clostridium difficile is reported to reside in healthy people, antibiotic treatment can lead to dis-
turbance in gut microbiota, which can lead to increase of Clostridium difficile in the gut and the
corresponding clinical conditions. In this case, gut microbiome serves as the mediator of the effect
of antibiotic use on clinical outcomes. Recent study has shown that intake of metformin changes
the gut microbiota composition in normoglycaemic young, which may be a determinant for de-
velopment of gastrointestinal adverse effects following metformin intake (Bryrup et al., 2019). In
this study, gut microbiome plays the mediating role to link metaformin treatment to gastrointestinal
adverse effects.
Mediation analysis can be used to address important scientific questions in many microbiome stud-
ies, where the goal is to understand the role of gut microbiome in linking the effects of treatment
or risk factors on the outcome. Classical mediation analysis usually considers a single mediator or
intervention variable and has strong theoretical foundations and extensive applications in medical
research and in economics (Imai, Keele, and Yamamoto, 2010; Pearl, 2000; Rubin, 2005). With
a continuous outcome, mediation analysis is often performed through structural linear equation
model. shown in (4.1), where M is the mediator, T represents treatment variable and Y is the
outcome variable. The mediation effect (or indirect effect) of T through M is the product of two two
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path coefficients a and b and the direct effect of T is the path coefficient c.
E(M) = a0 + aT, (4.1)
E(Y ) = b0 + cT + bM.
The path coefficients can be estimated based on the two linear models and the standard errors for
indirect effect ab is usually calculated by multivariate delta method, which relies on the assumption
that the asymptotic distribution of ab is approximately normal (Sobel, 1982). However, the distri-
bution of ab is usually skewed and several improvements have been proposed to address such an
asymmetry by constructing confidence intervals using the bootstrap method or using the product
of two normally distributed random variables (Bollen and Stine, 1990; Cheung, 2009; Shrout and
Bolger, 2002).
However, mediation analysis with microbiome as possible mediator is challenging. In typical 16S
rRNA sequencing studies, the microbiome data can be summarized as a matrix of sequencing read
counts, X = (x1, · · · ,xn)T , for n samples and q taxa, where xi = (xi1, · · · , xiq) is the vector of
read counts of q taxa in the ith sample. Such read counts are usually normalized into the matrix
of relative abundances of the bacterial taxa or are assumed to be sampled from a multinomial dis-
tribution with the underlying composition matrix P = (p1, · · · ,pn)T . Modeling such compositional
data is challenging due to the unit sum constraint (Li, 2015). Existing work extends the single medi-
ator framework with uncorrelated mediators or transformation of correlated mediators (Chén et al.,
2017; VanderWeele and Vansteelandt, 2014). The corresponding path coefficient a is estimated
one mediator at a time. However, those methods can not be applied to microbiome data due its
high-dimensionality and unit-sum constraint of the bacterial composition. Sohn and Li, 2019 devel-
oped the first methodology for compositional mediation analysis. In this work, the path coefficient
vector is jointly estimated without distributional assumptions and the high-dimensional problem is
alleviated through regularization. The joint and component-wise inference on the mediation effect
can be tested with properly defined null hypothesis and bootstrap confidence intervals.
Log-ratio of partitions of a composition p = (p1, · · · , pq), termed balance, was first introduced in
geology by Egozcue and Pawlowsky-Glahn (Egozcue and Pawlowsky-Glahn, 2005), and was re-
cently applied to microbiome studies with meaningful discoveries (Huang and Li, 2020; Morton et
65
al., 2017). Balance is defined as a weighted log ratio between two partitions of a compositional
vector. Let z = (z1, z2, . . . , zq) be a q-dimensional indicator vector with three values, 1, −1, and
0, where zi = 1 indicates that the corresponding part in the composition pi is in the numerator of
a ratio, zi = −1 indicates the denominator; and zi = 0 indicates the parts that are not a member
of the balance. Let z+, z−, and z0 be non-overlapping sets of indices of the elements in z whose












where | · | denotes the cardinality of a set. Balance roughly captures relative fold change between
two subgroups of taxa that compete against each other where the microbes within each subgroup
have symbiotic relationship. It provides a simple and useful quantity in describing the microbiota
community (Rivera-Pinto et al., 2018). In previous applications, the value of the indicator vector z
is chosen a priori based on a phylogenetic tree or some other biological knowledge (Morton et al.,
2017; Washburne et al., 2017). However, such information may be biased or even misleading since
the taxonomic positions do not always differentiate beneficial from detrimental taxa.
Based on this concept of balance, we propose a Bayesian balance mediation analysis, where bal-
ance serves as the mediator. Our model assumes that the treatment leads to change of balance of
the microbial community, which leads to the observed outcome. By introducing the balance as the
single mediator, we simplify the estimation of path coefficient b for the effect of treatment transmit-
ted through microbiota. The challenge of our proposed Bayesian balance mediation analysis is to
identify the sets z+ and z− that define the balance. We use the compositional algebra to quantify
how treatment shifts microbiome composition and the corresponding balance, where the path co-
efficient vector a is also compositional. We show that the indirect mediation effect of the treatment
is the multiplication of two quantities: the path coefficient b and the effect of balance determined by
the path vector a and balance indicator vector z. We then develop a MCMC algorithm to identify
the sets z+ and z− and to obtain the posterior predictive distribution of the mediation effect through
the estimated balance.
The main contribution of this paper is to incorporate the balance index into the compositional medi-
ation analysis. In such situation, the path coefficient a in Equation (4.1) will be replaced by a vector
value, represented by a. By introducing the balance index calculated from a compositional vector
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as the single mediator, we simplify the estimation of path coefficient b for the effect of treatment that
is transmitted through microbiota into a scalar value. The path coefficient vector a of how treat-
ment affects the microbiota is modeled as a hierarchical Bayesian model conditional on a balance
index. We also proved that mediation effect of treatment is a multiplication of two quantities given
the balance indicator z: the path coefficient b and applying the same transformation as the balance
index to the path cofficient vector a. We designed a sampling approach to sample parameters in
the proposed Bayesian Balance Mediation Model where the treatment is dichotomous and provided
posterior inferences on parameters of interest. Our method is different compared to Sohn and Li,
2019 in three main aspects: we assume a full parametric Bayesian model; the counts are realiza-
tion of underlying distribution; we can not estimate component wise mediation effect for a particular
taxon.
4.2. Bayesian balance mediation analysis
4.2.1. Notation
Consider a microbiome study with n i.i.d. samples from a population. Let y = (y1, · · · , yn) be the
vector of a continuous outcome of length n, and xi = (xi1, · · · , xiq) be the observed read counts
of q bacterial taxa with a total number of counts ni. The treatment assignment for subject i is
represented by a variable ti. For binary treatment, it takes value of 0 for sample that is untreated
and 1 for treated. Let pi = (pi1, · · · , piq) be a q-dimensional compositional vector representing the
relative abundance of q bacterial taxa for the ith sample. Let z is the q-dimensional indicator vector
for balance, where zj = 1 indicates pij in the z+ of the balance index, and zj = −1 indicates pij in
the z− of the balance index, and zj = 0 indicates that pij does not contribute to balance. We further
let bal() represent the balance defined by the compositional vector pi and the balance indicator
vector z, and let Bzi = bal(z,pi) be the balance calculated from pi and z for the ith sample.
Before introducing the Bayesian Balance Mediation Model (BBMM), we define several composi-















Since φ(·) is a one-to-one transformation, the inverse of additive logratio transformation φ−1(·) is
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uniquely defined. A ⊕ operator of two compositional vectors pi and pj is equivalent to renormalized
component-wise multiplication (Aitchison, 1982)
































4.2.2. Bayesian Balance Mediation Model
The key of our proposed BBMM is to associate the treatment ti, the observed count vector xi
and the outcome yi via the unobserved bacterial relative abundance vector pi and the balance
configuration vector z. We propose the following general hierarchical model:
xi ∼ Multinomial(ni,pi) (4.6)
pi = m0 ⊕ ati ⊕Ui (4.7)
Yi|pi, z = az + cz · ti + bz ·Bzi + ezi (4.8)
where m0 is the baseline composition, a is the compositional parameter that measures the effect
of ti on composition pi, and Ui is the random error for a compositional vector. We further let
βz = (az, cz, bz), wi = (1, ti, Bzi), and W = (w1, · · · ,wn)T .
For simplicity of presentation, we consider the case when the treatment ti takes binary 0/1 values,
as often seen in randomized clinical trial setting. We reparameterize the BBMM using mean val-
ues µ0,µ1 ∈ Rq−1 for the compositions after the additive logratio transformation. In addition, we
propose to use a logistic normal distribution (Billheimer, Guttorp, and Fagan, 2001) with mean 0
















Let µti = µ0(1− ti) + µ1ti, we then have an equivalent model for pi as model (4.7):
pi ∼ logistic normal(µ0(1− ti) + µ1ti,Σ).
By imposing distributional assumptions on Ui and ezi and prior distributions on parameters in the
BBMM, we can then draw posterior inferences on all model parameters. To complete the model,
we assume the standard conjugate priors for az, cz, bz, µ0, µ1, σ2 and Σ. Specifically, we assume
βz = (az, cz, bz) ∼MVN(β0,V ), (µ0,µ1)T ∼MVN(η,Ω),
σ2 ∼ invGamma(ν/2, λ/2), Σ−1 ∼Wq−1(ρ,Ψ−1),
where β0,V ,η,Ω, ν, λ, ρ and Ψ are the hyper-parameters. In this paper, following Billheimer, Gut-
torp, and Fagan, 2001, the hyperparameters are chosen as the following:
η = 0q−1,
Ω = k1(Iq−1 + jq−1j
T
q−1),
where k1 is a hyper parameter that we need to choose for the prior distribution and is fixed at
0.5, Iq−1 is the identify matrix, and jq−1 is the vector of ones. This corresponds to an evenly
distributed compositional vector whose 95% probability contour is around 0.05 for each component.
The degree of freedom ρ is often chosen as q − 1, and Ψ is a positive definite matrix, often chosen
as:
Ψ = k2(Iq−1 + jq−1j
T
q−1)
where k2 is chosen as 0.1. These corresponds to a weak prior for Σ−1.






2 (1− w1 − w2)p−m+−m− (4.9)
where w1 and w2 are the expected number of variables in z+ and z− group respectively. They affect
the sizes of taxa with positive and negative effects in the posterior inference of balance. A non-

















Figure 4.1: A graph diagram of the proposed Bayesian balance mediation analysis, where the
shaded circles present the data observed.
of w1 and w2 assume sparse structure of the balance. This prior has implicit assumptions that two
structures of a balance is as good as each other when the size of z+ and z− are approximately
equal. It is possible to relax the independence specification and use a dependent prior among
elements of z. Figure 4.1 shows the summary and the conditional independence structure of the
proposed BBMM.
4.2.3. Direct and mediation effect
In classical mediation analysis model (Equation (4.1)), under certain assumptions, the direct ef-
fect c and mediation effect ab of treatment on the continuous outcome can be estimated from
the coefficients in two linear models. The standard assumptions in mediation analysis include
0 < P (ti = t) < 1, 0 < P (pi = p|ti = t) < 1, no interference among the subjects and no interac-
tions between ti and pi. Besides these standard assumptions, two key conditional independence
assumptions under the potential outcome framework are also needed:
{yi(t′, log p),pi(t)} ⊥⊥ ti (4.10)
yi(t
′, log p) ⊥⊥ pi(t)|ti (4.11)
where yi(t′, log p) is the potential outcome when the treatmenet is set to t′ and the log-composition
is set to p, and pi(t) is the bacterial composition when the treatment is set to t. Assumption (4.10)
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requires that the treatment assignment is independent of the outcome and the relative abundance
vector pi, and assumption (4.11) states that given treatment, outcome is independent of the relative
abundance vector pi. Under these assumptions, we have the following Lemma linking the model
parameters to the direct and indirect mediation effects for a given balance configuration vector z.
Lemma 1 Under the above assumptions, for a given balance configuration vector z and the pro-
posed BBMM, specified by equations (4.6) - (4.8), the direct treatment effect on the outcome is
cz and the indirect mediation effect of the balance is the product of bal(z,a) and bz. For binary
treatment, the mediation effect of the balance is the product of bal(z, φ−1(µ1 − µ0)) and bz.
4.3. Model fit and inference via MCMC sampling
4.3.1. MCMC sampling
To obtain the estimates for all the unknown parameters in the model illustrated in Figure 4.1, we
propose a MCMC sampling procedure that combines the Gibbs and Metropolis-Hasting sampling.
The key component linking the two equations in Model (4.6) is pi. Conditioning on pi, we can




sample µ(1),Σ(1) based on X
sample z(1) based on y
⇒ sample p(1) based on X,y
⇒ sample b(1), c(1), σ2(1) . . .
where µ = (µ0,µ1)T . The detailed sampling steps for fitting the Bayesian balance mediation
models is presented as Algorithm 3.
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Algorithm 3: MCMC algorithm for the Bayesian balance mediation analysis
a. Initialize Σ(0),µ(0)0 ,µ
(0)
1 by sampling from their prior distributions.
b. Initialize p(0)i for each individual by sampling from f(pi|µti ,Σ).
c. Initialize z randomly or from the prior distribution.
d. Perform the following sampling iteratively, for the kth iteration:
(a) Sample Σ(k),µ(k)0 ,µ
(k)
1 from conditional distribution with closed form

















(b) As given pi, Xi, yi are independent, we can sample z(k) with Hastings sampling with
joint probability f(z(k), y|p(k−1)i ).
(c) Sample p(k)i with Hasting sampling, with logistic normal distribution centered at current





(d) Sample βz, σ2 from the closed form conditional distributions with current value of z and
all unknown values.
4.3.2. Conditional distributions
We present some details of the conditional distributions that are needed in the MCMC sampling








































Basing on this, we can obtain the following conditional distributional distributions for µk, k = 0, 1
and Σ (Gelfand et al., 1990),
µk|Σ,p ∼MVN(µ∗k,Σ∗k), for k = 0, 1,

























These conditional distributions are used to update µ0,µ1 and Σ in Step 4(a).
In order to sample pi for subject i, we notice that xi, yi are independent given pi. Treating all the
other unknowns as fixed, the conditional distribution of pi given the balance configuration is



































Σ−1 [φ(pi)− µti ]
)
where v, λ are the parameters for prior distribution of σ2 and
V ∗ = (V −1 +W TW )−1, (4.12)
u = V ∗(V −1β0 +W
Ty). (4.13)
We propose to sample pi from this distribution using the Metropolis-Hastings algorithm, where the
proposal distribution is logistic -normal centered at current pi and a fixed positive definite covariance
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matrix.
We then sample the balance configuration z using a similar sampling scheme as in Huang and
Li, 2020. For stochastic search of z, three possible value changes can occur during the random
exploration: i) between 0 and 1; ii) between 0 and −1; iii) between 1 and −1. Modifications be-
tween two values has three alterations: value conversions in either direction and value switch. We
set equal probabilities among all possible modifications, but such probabilities can be adjusted to
speed up the exploration of the sampling space. The joint distribution
∏
i f(pi,xi, yi, z) is used to
determine on accepting or rejecting the newly proposed z. Lastly, we flip the sign for z if the model
fitting between outcome and all the other variables in the regression model results in a negative
coefficient for balance. This is to ensure the identifiability of z. Finally, after we sample pi and z,
we sample βz and σ2 using the same sampling procedure as in Huang and Li, 2020.
4.3.3. Posterior inference
The convergence and mixing of the MCMC algorithm can be evaluated using different chains with
different starting points and by examining the cumulative moving average for each component of z.
After convergence, the posterior marginal inclusion probabilities for sets z+, z−, z0 are simply taken
as the marginal proportions of 1,−1, 0 in z. A threshold can be set to make inference on which set
of particular taxa should belong to the balance and the resulting balance definition.
Conditioning on z, we can obtain the predictive posterior distribution of the regression coefficients
βz. From model (4.8) and the normal prior distribution of βz, one can show that βz|Y, z has a




Ty − uTV ∗−1u
v + n
V ∗, (4.14)
where V ∗ and u are defined in (4.12) and (4.13). During each iteration of MCMC, we sample βz
from its posterior distribution and perform posterior inference for βz based on these sampling points.
Finally, at the convergence, due to randomness of z, the posterior samples of βz are averaged over
those z, which gives the mean of the predictive posterior distribution of βz based on model average.
Similarly, we can obtain the posterior predictive distribution of the mediation effect bal(z,a)× bz.
74
4.4. Simulation studies
We evaluate the proposed Bayesian balance mediation analysis for binary treatment using sim-
ulation studies by considering several different models with a range of unknown parameters and
hyperparameters. Our simulations from the previous chapters show similar performances of the
methods under uniform and sparse priors, we only evaluate our methods assuming a uniform prior
for the balance indicate vector z. We expect similar conclusions using the sparse prior.
4.4.1. Data generation
The simulated data are generated according to model illustrated in Figure 4.1, where n sample are
divided equally into two treatment groups. With the prespecified values for µ0,µ1,Σ, we generate
pi for each subject. The observed count xi is simulated from a multinomial distribution with the
total counts being equal for all the subjects. The outcome is generated by calculating the balance
index with pi and z.
We consider various combinations for true parameter values. We generate data for a total sample
size n = 100 with the compositional vector of dimension q = 10. The balance indicator vector z
has value 1 for the first 2 coordinates and -1 for the next two coordinate; the rest are all 0. For the
first three models (Model 1 - Model 3), we assume that the first 4 coordinates in mean parameters
of the logistic normal distribution in the untreated and treated group are µ1 = (1.4, 1.3, 1.2, 1.10
and µ0 = (1.1, 1.2, 1.3, 1.4), respectively, with the values in other components of the two mean
parameters being randomly generated from the standard normal distribution. We consider such a
setting in simulations in order to test how the unrelated values in compositional vector affect the
estimation. This setting simulates the scenario that the treatment affects microbial composition,
including the components that are nor relevant to the balance. The variance-covariance matrix Σ
is set to identity matrix with dimensionality q − 1. The path coefficients bz, cz in the second equation
are set to be 1.0, respectively. Finally, the random error is assumed to be normally distributed with
mean 0 and variance 1.
For the next three models, Model 4 - Model 6, we assume µ1 = µ0 = (1.1, 1.2, 1.3, 1.4) and all
other parameters are the same as in the previous models. This setting simulates the scenario
that the treatment does not affect the microbial composition, however, microbiome composition is
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associated with the continuous outcome through balance. Table 4.1 shows the effects of balance
on the outcome and the mediation effect for each of these 6 models.
Table 4.1: Parameters used in the simulations. True values for the first four components in the
population mean vector for the compositions in treated and untreated group, effect of balance on
outcome and mediation effect.
µ0 µ1 bal(a, z) bz mediation effect
Model 1 (1.1, 1.2, 1.3, 1.4) (1.4, 1.3, 1.2, 1.1) 0.4 1 0.4
Model 2 (1.1, 1.2, 1.3, 1.4) (1.4, 1.3, 1.2, 1.1) 0.4 0.5 0.2
Model 3 (1.1, 1.2, 1.3, 1.4) (1.4, 1.3, 1.2, 1.1) 0.4 0 0
Model 4 (1.1, 1.2, 1.3, 1.4) (1.1, 1.2, 1.3, 1.4) 0 1 0
Model 5 (1.1, 1.2, 1.3, 1.4) (1.1, 1.2, 1.3, 1.4) 0 0.5 0
Model 6 (1.1, 1.2, 1.3, 1.4) (1.1, 1.2, 1.3, 1.4) 0 0 0
4.4.2. Simulation results for models with mediation effect
Figure 4.2, Figure 4.3 and Figure 4.4 shows the results across 100 replications for the models
1-3, where the true µ0 and µ1 differ in the first four components and the treatment has effects on
microbiome composition.
For models with large or intermediate mediation effects, the MCMC algprithm is able to identify the
balance configurations z well, with the marginal posterior probability being the highest in the z+ for
the first 2 components, and highest in the z− set for the 3rd and 4th components. The posterior
mean of mediation effect is also centered around the true values. With bz = 0.5, we can correctly
recover the first four components of z but we also see that some taxa in the z0 set can have highest
posterior probability of being in the z+ group. With bz = 0, it is impossible to correctly recover
z. This observation is consistent with the updating step in MCMC, where only outcome Y and
latent relative matrix P are used to find the next sample of z. As Y contain less information with





























































































































(f) averaged across simulations
Figure 4.2: Simulation results for balance mediation analysis in Model 1 under uniform prior for
z. Pairwise posterior probabilities with all 100 simulations and averaged over 100 simulations are














































































































































(f) averaged across simulations
Figure 4.3: Simulation results for balance mediation analysis in Model 2 under uniform prior for
z. Pairwise posterior probabilities with all 100 simulations and averaged over 100 simulations are

























































































































































































































































































































































































































































































































































































































































































































































































(f) averaged across simulations
Figure 4.4: Simulation results for balance mediation analysis in Model 3 under uniform prior for
z. Pairwise posterior probabilities with all 100 simulations and averaged over 100 simulations are
plotted for taxa in the positive set z+ (red), negative set z− (blue) and null set z0 (yellow/green).
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4.4.3. Simulation results for models with no mediation effect
Figure 4.5, Figure 4.6 and Figure 4.7 shows similar results for models 4-6, where µ0 and µ1 are the
same and the treatment does not affect the microbiome composition. However, note that only the





























































































































(f) averaged across simulations
Figure 4.5: Simulation results for balance mediation analysis in Model 4 under uniform prior for
z. Pairwise posterior probabilities with all 100 simulations and averaged over 100 simulations are


























































































































































(f) averaged across simulations
Figure 4.6: Simulation results for balance mediation analysis in Model 5 under uniform prior for
z. Pairwise posterior probabilities with all 100 simulations and averaged over 100 simulations are





























































































































































































































































































































































































































































































































































































































































































































































































































(f) averaged across simulations
Figure 4.7: Simulation results for balance mediation analysis in Model 6 under uniform prior for
z. Pairwise posterior probabilities with all 100 simulations and averaged over 100 simulations are
plotted for taxa in the positive set z+ (red), negative set z− (blue) and null set z0 (yellow/green).
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4.4.4. Posterior inference of mediation effect
The estimation of posterior mean of the mediation effect (Figure 4.8 and Figure 4.9)has a positive
bias when bz = 0 and the corresponding mediation effect is zero. This is because during MCMC
sampling for the purpose of identifiability of the balance configuration, we choose the next sampling
















































(c) β1z = 0











































(c) β1z = 0
Figure 4.9: Boxplots of the posterior mean of the mediation effect over 100 simulations for Model 4
to Model 6.
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4.5. Applications to mediation analysis of plasma metabolomics data
4.5.1. Summary of serum metabolites
Wu et al., 2016 reported a study that used 16S rRNA-tagged sequencing as well as plasma and
urinary metabolomic platforms, to compare the measures of dietary intake, gut microbiota compo-
sition and the plasma metabolome between 15 healthy human vegans and 16 omnivores, sampled
in an urban USA environment. One important question is to understand how diet affects plasma
metabolites and how much such effects are mediated through gut microbiome.
Compared to urine metabolites, we focus on analyzing serum metabolites since it is more related
to diet and gut microbiome. The data set includes 349 serum metabolites that belong to 9 path-
ways: amino acid, carbohydrate, cofactors and vitamins, energy, lipid, nucleotide, peptide, sec-
ondary metabolism, and xenobiotics. Due to the limited sample sizes, we select the following
serum metabolites in our analyses: 4-ethylphenyl sulfate, 3-hydroxyhippurate,hippurate and cate-
chol sulfate. These four metabolites belong to the same Xenobiotics Benzoate metabolism pathway
and are statistically significantly different among two diet groups (Figure 4.10). They are also the
products of gut microbiota, so it is of interest to dissect how much of the difference in these metabo-
lites between the two diet groups attributes to microbiota. By restricting our analysis to only a few



































Figure 4.10: Boxplots of four selected metabolites for each diet group. The between group differ-
ences are statistically significant with p < 0.05.
4.5.2. Mediation analysis at the phylum level
Our first analysis is used as a proof-of-concept of our proposed methods, where we summarize the
bacterial count data at the phylum level. For each sample, we have read counts for each of the five
different phyla, including Actinobacteria, Bacteroidetes,Cyanobacteria, Firmicutes, and Proteobac-
treria. In our analysis, we choose Proteobactreria as the reference phylum in the logistic-normal
distribution in modeling the taxon composition. Figure 4.11 shows the plot of the posterior distribu-
tion of the balance configuration of four bacterial phyla in Bayesian balance mediation analysis of
the effect of vegan diet on the selected serum metabolites under sparse prior The posterior plots
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indicate that the ratio of phyla Firmicutes and Bacteroides defines the balance that mediates the
effect of vegan diet on all six metabolites. Indeed, the ratio of the relative abundance of phylum
Firmicutes and phylum Bacteroides has been shown to be associated with fat intake and also diet
in multiple previous publications (Holmes et al., 2011; Tomova et al., 2019). Figure 4.12 shows the
posterior mean of the relative abundance of each phylum in the two diet groups, indicating a weak

















































Figure 4.11: Plot of the posterior distribution of the balance configuration of five bacterial phyla
in Bayesian balance mediation analysis of the effect of vegan diet on different serum metabolites
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Figure 4.12: Plot of the posterior mean of the relative abundance of each phylum under the sparse
prior of z. Solid line represents equal proportions in vegan and omnivore diet group.
Under the uniform prior, the configuration of identified balance are similar to those under sparse
prior (Figure 4.13) and the estimated relative abundance are also similar (Figure 4.14). In some
scenarios, more phyla are included in the balance. This is expected because with uniform prior the


















































Figure 4.13: Plot of the posterior distribution of the balance configuration of five bacterial phyla
in Bayesian balance mediation analysis of the effect of vegan diet on different serum metabolites
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Figure 4.14: Plot of the posterior mean of the relative abundance of each phylum under the uniform
prior of z. Solid line represents equal proportions in vegan and omnivore diet group.
Table 4.2 shows that estimated direct effect of vegan diet on each metabolite and the mediation
effect of the identified balance and their 95 credible intervals. We observe a strong direct effect
of vegan diet on each of the metabolites and also moderate effect of the identified balance on
metabolites, but a relatively weak mediating effect of the balance. This is largely explained by the
relatively weak effect of diet on microbiome composition (see Figures 4.12 and 4.14).
One interesting observation in our phylum level analysis is that balance configuration is reversed for
3-hydroxyhippurate compared to the other three metabolites. This indicates that there is a negative
correlation between 3-hydroxyhippurate and the other three. We further examined the data and
observed that such a negative correlation is more prominent in subjects with vegan diet, indicating
that the balance identified in our analysis is indeed mediating the effect of vegan diet on different
metabolites. However, due to the limited sample size of our data, the effect did not reach statistical
significance.
90
Table 4.2: Results of Bayesian balance mediation analysis at the phylum level under uniform and
sparse priors. The table shows the estimation of direct, mediation effects on vegan diet on differ-
ent metabolites and the effect of balance on each metabolite, based on the predictive posterior
distributions.
Uniform prior
4-ethylphenyl sulfate 3-hydroxyhippurate hippurate catechol sulfate
Vegan (T ) 14.83(14.2,15.73) 1.1(0.89,1.45) 1.33(1.23,1.48) 0.73(0.71,0.77)
Balance 1.18(0,3.53) 0.05(0,0.37) 0.42(0,0.91) 0.24(0,0.38)
Mediation 0.22(-0.47, 1.58), -0.01 (-0.12 , 0.02) 0.09 (-0.13, 0.50) 0.04 (-0.09,0.21)
Sparse prior
4-ethylphenyl sulfate 3-hydroxyhippurate hippurate catechol sulfate
Vegan(T ) 14.67(14.48,16.01) 1.18(0.97,1.25) 1.28(1.26,1.37) 0.72(0.71,0.76)
Balance 2.54(0.01,3.69) 0.23(0,0.42) 0.8(0,0.92) 0.33(0,0.38)
Mediation 0.51(-0.71,1.95) -0.04(-0.21,0.07) 0.18(-0.18,0.56) 0.06(-0.09,0.23)
4.5.3. Analysis at the family level
Our second analysis is performed at the family level, where we summarize the bacterial counts
data at the family level, and for each sample, we have read counts for each of the 16 different
families, including Alcaligenaceae, Bacteroidaceae, Barnesiellaceae, Clostridiaceae, Coriobacte-
riaceae, Erysipelotrichaceae, Lachnospiraceae, Mogibacteriaceae, Odoribacteraceae, Oxalobac-
teraceae, Porphyromonadaceae, Prevotellaceae, Rikenellaceae, Ruminococcaceae, Streptococ-
caceae , and Veillonellaceae. In our analysis, we choose Clostridiales as the reference family in
the logistic-normal distribution. Figure 4.15 shows the plot of the posterior distribution of the balance
configuration of bacterial families in Bayesian balance mediation analysis of the effect of vegan diet
on selected serum metabolites, where uniform prior is assumed. With family level data, the balance
defined in the mediation analysis differ among different metabolites. More specifically, ratio between
Barnesiellaceae, oxalobacteraceae and clostridiaceae defines the balance that mediates the effect
of vegan diet on 4-ethylphenyl sulfate. For 3-hydroxyhippurate, the balance is defined by the ratio
between Bacteroidaceae,Clostridiaceae,Lapchnospiraceae,Mogibacteriaceae,Veillonellaceae and
Erysipelotrichaceae, Odoribacteraceae, Porphyromonadaceae. For hippurate, balance is defined



























































































(c) hippurate (d) catechol sulfate
Figure 4.15: Plot of the posterior distribution of the balance configuration of 16 bacterial families
in Bayesian balance mediation analysis of the effect of vegan diet on different serum metabolites
under a uniform prior for z.
laceae, Veillonellaceae. For catechol sulfate, no clear balance can be identified that mediate the
effect of vegan diet. The balance identified at the family level differs among different metabolites
indicates that different groups of bacteria involve in the generation of these metabolites, which is
supported by multiple publications(Besten et al., 2013; Morrison and Preston, 2016).
Under the sparse prior, no clear balance can be identified for these metabolites (see Figure 4.16)
except for 3-hydroxyhippurate. This is largely due to the small sample sizes in our study.



























































































(c) hippurate (d) catechol sulfate
Figure 4.16: Plot of the posterior distribution of the balance configuration of 16 bacterial families
in Bayesian balance mediation analysis of the effect of vegan diet on different serum metabolites
under a sparse prior for z.
effect by the identified balance and their 95 credible intervals under both uniform and sparse priors.
The estimated direct effect and mediation effect are similar to our analysis at the phylum level but
the credible intervals are wider, indicating greater uncertainty. The identified balance is associated
with the metabolite levels, but there is no mediation effect of the identified balance.
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Table 4.3: Results of Bayesian balance mediation analysis of four serum metabolites at the family
level under uniform for z and sparse priors. The table shows the estimation of direct, mediation
effects on vegan diet on different metabolites and the effect of balance on each metabolite, based
on the predictive posterior distributions.
Uniform prior
4-ethylphenyl sulfate 3-hydroxyhippurate hippurate catechol sulfate
Vegan(T ) 14.48(12.35,16.71) 1.16(0.66,1.57) 1.43(0.95,1.93) 0.70(0.61,0.78)
Balance 1.09(0.11,2.65) 0.26(0.04,0.5) 0.23(0.03,0.46) 0.04(0,0.09)
Mediation 0.03(-1.71,1.87) 0.02(-0.39,0.45) -0.04 (-0.46,0.36) 0(-0.07,0.07)
Sparse prior
4-ethylphenyl sulfate 3-hydroxyhippurate hippurate catechol sulfate
Vegan(T ) 13.95(11.41,16.07) 1.19(0.84,1.62) 1.49(1.24,1.73) 0.71(0.62,0.79)
Balance 0.90(0.07,2.44) 0.24(0.08,0.49) 0.22(0.04,0.46) 0.04(0,0.11)
Mediation 0.17 (-1.33,2.14) 0.03 (-0.32, 0.38) -0.07 (-0.40, 0.21) 0(-0.06,0.07)
4.6. Application to mediation analysis of COMBO data
We also apply the Bayesian balance mediation analysis to a cross-sectional study of 98 healthy
volunteers as reported in Wu et al., 2011. The dataset consists of 16SrRNA sequences from fecal
samples of 98 healthy individuals from the University of Pennsylvania. It also contains demographic
and clinical information including fat intake and BMI, where the habitual long-term fat intake was
derived from the food frequency questionnaire (FFQ). Such measurements are widely applied in
nutritional research, and their reproducibility and validity have been validated (Hu et al., 1999). We
summarized operational taxonomic units (OTUs) at the genus level and then filtered out the genera
that appear in fewer than 10% of the samples, leaving 45 genera in 98 samples. These 45 genera
can be further grouped into 5 phyla and 8 orders.
We apply the proposed Bayesian mediation analysis to investigate the mediating effect of gut mi-
crobiome in linking high fat intake and BMI.
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4.6.1. Mediation analysis of the COMBO data at the phylum level
Our first analysis is used as a proof-of-concept of our proposed methods, where we summarize
the bacterial count data at the phylum level. For each sample, we have read counts for each of
the five different phyla, including Actinobacteria, Bacteroidetes, Firmicutes, and Proteobactreria. In
our analysis, we choose Proteobactreria as the reference phylum in the logistic-normal distribution
in modeling the taxon composition. Figure 4.17 shows the plot of the posterior distribution of the
balance configuration of four bacterial phyla in Bayesian balance mediation analysis of the effect
of high-fat on BMI under both uniform prior and sparse priors. Since the number of phyla is small,
we expect that both uniform-prior and sparse-prior give similar results. The posterior plots indicate
that the ratio of phyla Firmicutes and Bacteroides defines the balance that mediates the effect of
high fat on BMI. Indeed, the ratio of the relative abundance of phylum Firmicutes and phylum Bac-
teroides has been shown to be associated with fat intake and also the obesity in multiple previous

























(a) uniform prior (b) sparse prior
Figure 4.17: The posterior distributions of the balance configuration of four bacterial phyla in
Bayesian balance mediation analysis of the effect of high-fat on BMI under uniform and sparse
prior for z, respectively.
Table 4.4 shows that estimated direct effect of high fat on BMI and the mediation effect of the
identified balance and their 95 credible intervals. We observe a strong direct effect of high fat on
BMI and also the strong effect of the identified balance on the BMI, but a relatively weak mediating
effect of the balance.
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Table 4.4: Results of Bayesian balance mediation analysis at phylum and order level, assuming
uniform or sparse prior for z. The table shows the estimation of direct, mediation effects on high-fat
on BMI and the effect of balance on BMI. based on the predictive posterior distributions.
Phylum level Order level
Uniform Prior Sparse Prior Uniform prior Sparse prior
High fat(T ) 1.90 (1.01,2.10) 2.01 (0.99,2.10) 1.46 (1.02,2.06) 1.86 (1.15,2.11
Balance 0.69 (0,0.92) 0.84 (0.01,0.92) 0.04 (0,0.86) 0.58 (0,0.92)
Mediation 0.17 (-0.76,1.04) 0.19 (-0.32,0.83) 0.03 (-2.12,2.19) 0.19(-1.33,1.50)
4.6.2. Analysis at the order level
Our second analysis is performed at the order level, where we summarize the baterical counts data
at the order level, and for each sample, we have read count for each of the 8 different orders, includ-
ing Coriobacteriales, Bacteroidales, Bacillales, Lactobacillales, Clostridiales, Erysipelotrichales,
and Burkholderiales. In our analysis, we choose Burkholderiales as the reference order in the
logistic-normal distribution. Figure 4.18 shows the plot of the posterior distributions of the balance
configuration of seven bacterial orders in Bayesian balance mediation analysis of the effect of high-
fat on BMI. Under the uniform prior, no clear balance can be identified that mediate the effect of high
fat on MBI. Under the sparse prior, the plot indicates that the ratio of order of Costridiales and order
Bacteroidels defines the balance that mediates the effect of high fat on BMI. Since Clostridiales be-
long to phylum Frmicutes and Bacteroidales belongs to phylum Bacteroide, the balance identified






























(a) Uniform prior (b) Sparse prior
Figure 4.18: Plot of the posterior distribution of the balance configuration of 7 bacterial orders in
Bayesian balance mediation analysis of the effect of high-fat on BMI.
Table 4.4 shows the estimate of the direct effect of high fat on BMI and the mediation effect by the
identified balance and their 95 credible intervals. The estimated direct effect and mediation effect
are similar to our analysis at the phylum level. We observe a strong direct effect of high fat on BMI
and strong effect of the balance identified on BMI, but a relatively weak mediating effect.
4.7. Discussion
In this work, we have described a general Bayesian balance mediation model that extends the
compositional mediation analysis via the balance index introduced in earlier chapters. The balance
is able to characterize a microbiome sample with a single scalar and the mediation analysis based
on the balance index is advantageous with regard to dimension reduction and model interpretation.
We have developed a generative model in a Bayesian framework to jointly model the taxon read
counts and an continuous outcome variable via the latent bacterial compositions. In particular, we
have developed a two group mediation analysis method where the treatment/exposure is a binary
variable in order to estimate the treatment effect that is mediated through perturbing the microbiome
composition. We have developed a hybrid Gibbs-Metropolis sampling algorithm to sample all the
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unknown quantities from the posterior distributions. The mean vector and variance matrix for the
compositions in the treated and untreated groups are updated with the observed count as well
as the latent relative abundance, while the balance indicator is updated using the latent relative
abundance and the outcomes. The estimates for path coefficients and the indirect mediation effects
are calculated for each sampling realization and are used for posterior inference. Simulation studies
have shown the effectiveness of the proposed methods in identifying the mediating balance and its
mediation effect.
Our proposed balance mediation model is fully parametric, which facilitates sampling from the pos-
terior distributions. The posterior sampling makes statistical inference easier than the traditional
mediation analysis methods or other high dimensional compositional mediation analysis, which of-
ten rely on bootstrapping. On the other hand, similar to all Bayesian methods, our method can be
sensitive to hyperparameters when sample size is small. In the case when we have enough data,
the impact of the prior distributions on the inference is minimal. However, when the sample size is
small, the posterior distributions can be dominated by the prior distributions of the parameters. As
we observed in our real data analysis, when the sample sizes are small, uniform or sparse prior
assumption on the balance configuration vector z can lead to identifying different sets of taxa that
define the balance.
The proposed Bayesian mediation analysis is computational intensive. Since the latent relative
abundance matrix P needs to be sampled at each iteration, if n and q are big, it can take a con-
siderable time even to run a couple hundred iterations. In high dimensional settings, we have to
run many steps of the posterior sampling in order to reach convergence. The benchmark for all the
simulation studies presented above is 3 minutes and 7 seconds for n = 100, q = 10 with 3 ∗ 104 total
iterations. In our analysis of the real data sets, we have focused our analysis at the phylum or family
level, where the number of taxa q is relatively small, which usually takes several minutes. When we
apply the methods to the compositional data at the species level, we expect longer running time.
For such a high dimensional taxa composition, it makes more biological sense to identify smaller
balance by assuming a sparse prior on the balance configuration.
There are several potential extensions to our proposed model. First, in relating the relative abun-
dance to count data, we use a multinomial model. It is possible to model the microbiome count data
using some zero inflated modes, due to the sparsity of the data from microbiome studies. However,
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if we can aggregate the data into higher levels on the taxonomy tree and remove the taxon that only
appears in less than 10% subjects, a multinomial model is often sufficient. Second, although for
simplicity, we present our mediation analysis for binary treatment, the model and the methods can
be similarly extended for continuous treatment and for including covariates. For binary treatment,
there is a one-to-one correspondence between a and µ0,µ1. For general continuous factor Tj , we
can replace the location parameters µ0,µ1 in the distribution of p by β0 +β1(Tj − T̄ ). This param-
eterization allows interpretation of β0 as the location of log-ratio transformation of the compositions
when Tj = T̄ and β1 as the change in location for a unit change in Tj . In this case, the mediation
effect can still be quantified by bal(a, z) × bz for a given balance configuration z. Similar MCMC
algorithm can be developed.
In our real data analysis, the mediation effect of the identified balance is relatively weak compared
to the direct effect of vegan diet on all four metabolites. The production of the selected metabolites
requires substrate (fiber-rich food) as well as gut microbiota. As the original study pointed out (Wu
et al., 2016), there is only a small difference in the composition of gut microbiota between subjects
with vegan and omnivore diet, the observed elevated level of the four metabolites in vegan diet is
probably due to the availability of fiber-rich food. The changes in composition of microbiota is slow
with a shift in diet pattern. A future study with a sufficiently large number of subjects who are on
vegan diet for a long time would lead to a thorough understanding of the balance configuration and
its role in mediating the effect of vegan diet on each of the metabolite.
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CHAPTER 5
CONCLUSION AND FUTURE DIRECTION
5.1. Discussion and conclusions
This thesis work develops novel Bayesian balance regression and Bayesian balance mediation
analysis in order to identify that microbial compositional balance that is associated with outcomes
or serves as possible mediator between treatment and outcome. Our approaches overcome two
major challenges in analysis of microbiome data, high-dimensionality and compositional nature
of the data. The balance provides a summary measure of dysbiosis of the microbial community.
With the balance index, physicians are able to evaluate a patient’s gut microbiota healthy status or
his/her risk of getting a particular gastrointestinal disease, or even assess whether a treatment is
effective for a specific patient. The simple calculation and easy use of a scalar measure derived
from a high dimensional compositional data can potentially facilitate the use of microbiome data in
medical practice.
Throughout my thesis work, I have explored how to extract the balance index under different statis-
tical models, which may have direct medical applications. The main theme is to recover the balance
index in the regression setting, where the balance composition can be recovered as well as its as-
sociation with an outcome. The MCMC sampling algorithms for the proposed Bayesian regression
and Bayesian mediation analysis enable efficient exploration of the large latent space of balance
indicator. To speed up the convergence of Markov chains, the unrelated parameters are integrated
out. For binary outcome regression, we use the probit link function because there is simple one-to-
one correspondence between the probit model and linear model. By augmenting the data with an
unobserved latent continuous variable, a new sampling procedure is introduced where the latent
variable is first updated and then the recovery of a balance index is performed with the new value
of latent variable. For the proposed Bayesian mediation analysis, balance index and compositional
vector are introduced into the linear structure equation model. In this work, we directly model the
count data and use the unobserved microbiome composition to associate the bacterial read counts
and the outcome.
Like all Bayesian methods, the choice of prior distributions might impact the results if the sample
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size is not large enough. However, if there is strong evidence supporting a particular choice of
prior distributions, it should definitely help to recover the balance index using additional data. When
researchers have no prior knowledge, an uninformative or a flat prior is often chosen, and in such
case, the results are largely driven by data. The second drawback of the proposed Bayesian
approach is computation cost and time. MCMC sampling requires a lot of computational time
even we integrate out the unrelated parameters in the model when sampling the balance index. In
recovering the balance index using probit model, an additional step is required to sample the latent
variable from a truncated multivariate normal distribution. This step deteriorates the performance of
proposed method further. Similarly, in the balance mediation model, the relative abundance vector
for all subjects are latent, which requires additional sampling steps and more computational time.
5.2. Future work
The balance presents a simple and yet powerful summary of microbiome composition that can be
used as a measure of dysbiosis of a microbial community. In addition to what I have completed
so far, the balance index can fit into any statistical models for high dimensional compositional data.
For example, instead of a binary outcome, we can incorporate balance index to a generalized linear
model and Cox proportional hazards regression model. Similarly we can build balance mediation
model for different type of outcome data. Due to the power of Bayesian sampling and posterior
inference, we can estimate parameters from a much complex model even without closed-form ex-
pressions of the posterior distribution.
Besides possible extensions of the balance regression to various other types of regression prob-
lems, another interesting question is to identify the balance in an unsupervised setting. Inspired
by the PCA where the first principle component corresponds to the direction that has the largest
variance, it is interesting to identify balance that has the largest variance among given samples.
Let xi be the compositional vector for the ith sample in a given study of n independent samples,












This optimization can be solved using the adaptive hyperbox algorithm developed for high dimen-
sional discrete optimization (Xu, Nelson, and Hong, 2013).
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APPENDIX A
ADDITIONAL REAL DATA ANALYSIS RESULTS UNDER DIFFERENT MCMC INITIAL
VALUES
A.1. Chapter 2 - additional results on analysis of COMBO and UK twin data sets
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A.1.1. Additional results on COMBO data
Table A.1: Posterior probabilities with 5 starting values under uniform prior. Results are from
COMBO data at the genus level.
starting 1 starting 2 starting 3 starting 4 starting 5
set z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0
Collinsella 0.16 0.50 0.34 0.15 0.51 0.34 0.15 0.51 0.34 0.17 0.49 0.34 0.16 0.49 0.35
Eggerthella 0.23 0.41 0.36 0.24 0.43 0.34 0.24 0.41 0.35 0.23 0.42 0.35 0.24 0.42 0.34
Bacteroides 0.34 0.32 0.34 0.34 0.31 0.34 0.34 0.31 0.35 0.33 0.32 0.35 0.34 0.31 0.34
Barnesiella 0.19 0.17 0.64 0.19 0.17 0.64 0.19 0.16 0.65 0.20 0.19 0.62 0.19 0.19 0.62
Butyricimonas 0.12 0.41 0.47 0.12 0.43 0.45 0.12 0.41 0.47 0.12 0.42 0.45 0.11 0.42 0.46
Odoribacter 0.06 0.57 0.38 0.05 0.57 0.38 0.05 0.59 0.36 0.07 0.56 0.37 0.06 0.56 0.38
Parabacteroides 0.32 0.26 0.42 0.31 0.24 0.45 0.31 0.25 0.44 0.34 0.24 0.42 0.33 0.25 0.42
Paraprevotella 0.25 0.29 0.47 0.25 0.29 0.47 0.25 0.28 0.47 0.26 0.28 0.45 0.26 0.28 0.46
Prevotella 0.04 0.46 0.49 0.04 0.45 0.51 0.04 0.48 0.48 0.05 0.44 0.51 0.04 0.45 0.51
Alistipes 0.02 0.79 0.19 0.02 0.78 0.20 0.02 0.80 0.18 0.02 0.77 0.21 0.02 0.79 0.19
Gemella 0.32 0.34 0.34 0.31 0.35 0.34 0.30 0.35 0.35 0.31 0.35 0.34 0.32 0.35 0.33
Granulicatella 0.33 0.33 0.34 0.32 0.33 0.35 0.33 0.33 0.34 0.34 0.34 0.32 0.35 0.33 0.32
Lactobacillus 0.25 0.37 0.38 0.28 0.35 0.37 0.26 0.37 0.38 0.29 0.34 0.37 0.26 0.38 0.36
Streptococcus 0.23 0.38 0.39 0.24 0.38 0.38 0.25 0.37 0.38 0.25 0.36 0.39 0.25 0.37 0.38
Clostridium 0.03 0.79 0.18 0.03 0.77 0.20 0.03 0.80 0.17 0.03 0.78 0.18 0.03 0.79 0.18
Anaerofustis 0.30 0.35 0.35 0.31 0.33 0.36 0.31 0.35 0.34 0.32 0.33 0.35 0.31 0.36 0.33
Eubacterium 0.20 0.32 0.48 0.21 0.31 0.48 0.20 0.32 0.48 0.21 0.32 0.46 0.21 0.33 0.47
Anaerovorax 0.16 0.51 0.33 0.14 0.51 0.35 0.14 0.51 0.35 0.14 0.51 0.35 0.14 0.51 0.35
Mogibacterium 0.44 0.23 0.33 0.46 0.22 0.32 0.44 0.24 0.32 0.45 0.24 0.31 0.43 0.25 0.32
Blautia 0.31 0.31 0.39 0.32 0.33 0.35 0.32 0.32 0.36 0.32 0.31 0.37 0.31 0.33 0.36
Coprococcus 0.21 0.37 0.43 0.19 0.38 0.43 0.20 0.37 0.43 0.23 0.36 0.41 0.21 0.36 0.42
Dorea 0.66 0.08 0.25 0.67 0.09 0.25 0.69 0.08 0.23 0.69 0.08 0.23 0.68 0.09 0.24
Roseburia 0.10 0.56 0.35 0.09 0.57 0.34 0.10 0.57 0.33 0.11 0.56 0.33 0.10 0.55 0.35
Anaerofilum 0.23 0.42 0.34 0.23 0.43 0.34 0.22 0.43 0.35 0.24 0.43 0.34 0.23 0.42 0.35
Anaerotruncus 0.17 0.42 0.40 0.18 0.44 0.38 0.17 0.45 0.38 0.19 0.42 0.39 0.17 0.43 0.41
Butyricicoccus 0.27 0.35 0.38 0.26 0.34 0.39 0.27 0.34 0.38 0.28 0.32 0.40 0.29 0.34 0.37
Faecalibacterium 0.48 0.16 0.36 0.50 0.15 0.35 0.50 0.16 0.34 0.49 0.16 0.35 0.46 0.18 0.36
Oscillibacter 0.04 0.73 0.23 0.04 0.72 0.24 0.03 0.73 0.24 0.04 0.74 0.22 0.03 0.72 0.24
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Table A.1: Posterior probabilities with 5 starting values under uniform prior. Results are from
COMBO data at the genus level.
starting 1 starting 2 starting 3 starting 4 starting 5
set z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0
Ruminococcus 0.58 0.08 0.34 0.60 0.08 0.32 0.62 0.06 0.32 0.59 0.08 0.33 0.61 0.08 0.31
Subdoligranulum 0.35 0.21 0.44 0.34 0.21 0.44 0.35 0.21 0.44 0.33 0.21 0.46 0.33 0.22 0.44
Acidaminococcus 0.95 0.00 0.04 0.95 0.01 0.05 0.95 0.01 0.04 0.94 0.01 0.06 0.94 0.01 0.06
Allisonella 0.78 0.05 0.16 0.78 0.06 0.16 0.78 0.05 0.17 0.77 0.06 0.18 0.76 0.06 0.18
Dialister 0.03 0.62 0.35 0.03 0.61 0.36 0.03 0.63 0.34 0.04 0.63 0.33 0.04 0.64 0.32
Megamonas 0.06 0.69 0.25 0.05 0.69 0.26 0.06 0.66 0.27 0.07 0.67 0.26 0.06 0.69 0.25
Megasphaera 0.79 0.04 0.17 0.77 0.04 0.19 0.80 0.04 0.16 0.78 0.05 0.17 0.77 0.05 0.17
P. faecium 0.06 0.43 0.51 0.07 0.42 0.51 0.06 0.43 0.50 0.06 0.44 0.50 0.06 0.43 0.51
Veillonella 0.13 0.53 0.34 0.12 0.53 0.35 0.12 0.54 0.34 0.13 0.53 0.34 0.13 0.54 0.33
Catenibacterium 0.74 0.06 0.20 0.73 0.06 0.21 0.73 0.06 0.22 0.71 0.06 0.23 0.72 0.07 0.21
Coprobacillus 0.04 0.66 0.30 0.04 0.67 0.29 0.05 0.66 0.30 0.04 0.66 0.30 0.05 0.66 0.29
Holdemania 0.25 0.35 0.40 0.26 0.36 0.37 0.27 0.33 0.40 0.27 0.35 0.38 0.27 0.34 0.39
Solobacterium 0.26 0.40 0.34 0.25 0.40 0.35 0.26 0.39 0.35 0.28 0.37 0.36 0.26 0.39 0.35
Turicibacter 0.38 0.28 0.34 0.36 0.25 0.38 0.37 0.28 0.36 0.37 0.28 0.35 0.37 0.28 0.35
Parasutterella 0.14 0.34 0.51 0.13 0.34 0.53 0.14 0.36 0.50 0.17 0.35 0.48 0.14 0.36 0.50
Sutterella 0.21 0.30 0.49 0.21 0.30 0.49 0.20 0.30 0.50 0.23 0.29 0.48 0.21 0.32 0.47
Oxalobacter 0.17 0.48 0.35 0.19 0.48 0.33 0.18 0.50 0.32 0.19 0.47 0.34 0.18 0.47 0.35
Table A.2: Posterior probabilities with 5 starting values under sparse prior. Results are from
COMBO data at the genus level.
starting 1 starting 2 starting 3 starting 4 starting 5
set z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0
Collinsella 0.02 0.18 0.80 0.01 0.19 0.79 0.01 0.20 0.78 0.01 0.21 0.78 0.01 0.19 0.79
Eggerthella 0.03 0.18 0.79 0.03 0.20 0.77 0.03 0.18 0.79 0.03 0.19 0.79 0.02 0.20 0.78
Bacteroides 0.08 0.06 0.87 0.07 0.06 0.87 0.07 0.06 0.88 0.07 0.07 0.86 0.07 0.07 0.86
Barnesiella 0.00 0.01 0.99 0.00 0.01 0.99 0.01 0.01 0.99 0.00 0.01 0.99 0.00 0.01 0.99
Butyricimonas 0.00 0.03 0.96 0.01 0.03 0.96 0.00 0.03 0.96 0.00 0.03 0.97 0.01 0.03 0.96
Odoribacter 0.00 0.07 0.93 0.01 0.07 0.93 0.01 0.07 0.92 0.00 0.08 0.92 0.00 0.05 0.94
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Table A.2: Posterior probabilities with 5 starting values under sparse prior. Results are from
COMBO data at the genus level.
starting 1 starting 2 starting 3 starting 4 starting 5
set z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0
Parabacteroides 0.02 0.02 0.95 0.02 0.03 0.95 0.02 0.03 0.95 0.02 0.03 0.95 0.02 0.03 0.95
Paraprevotella 0.01 0.03 0.97 0.01 0.03 0.97 0.01 0.03 0.96 0.01 0.03 0.96 0.01 0.03 0.97
Prevotella 0.00 0.03 0.97 0.00 0.03 0.97 0.00 0.03 0.97 0.00 0.03 0.97 0.00 0.03 0.97
Alistipes 0.00 0.64 0.36 0.00 0.62 0.38 0.00 0.64 0.36 0.00 0.61 0.39 0.00 0.65 0.35
Gemella 0.07 0.12 0.81 0.07 0.11 0.81 0.08 0.12 0.81 0.07 0.12 0.81 0.07 0.12 0.81
Granulicatella 0.08 0.10 0.82 0.07 0.10 0.83 0.07 0.09 0.84 0.07 0.10 0.83 0.07 0.10 0.83
Lactobacillus 0.03 0.08 0.89 0.04 0.09 0.88 0.04 0.10 0.86 0.04 0.10 0.87 0.03 0.10 0.86
Streptococcus 0.02 0.06 0.92 0.02 0.07 0.91 0.02 0.07 0.91 0.02 0.07 0.92 0.02 0.06 0.92
Clostridium 0.00 0.81 0.19 0.00 0.78 0.22 0.00 0.79 0.21 0.00 0.76 0.24 0.00 0.78 0.22
Anaerofustis 0.07 0.12 0.81 0.07 0.13 0.80 0.07 0.12 0.81 0.07 0.13 0.80 0.07 0.12 0.81
Eubacterium 0.01 0.04 0.96 0.01 0.03 0.96 0.01 0.03 0.96 0.01 0.04 0.96 0.01 0.04 0.96
Anaerovorax 0.02 0.15 0.83 0.01 0.15 0.84 0.02 0.15 0.83 0.02 0.14 0.84 0.02 0.16 0.82
Mogibacterium 0.13 0.05 0.81 0.15 0.04 0.81 0.13 0.05 0.82 0.13 0.05 0.81 0.14 0.05 0.81
Blautia 0.04 0.06 0.90 0.05 0.06 0.89 0.04 0.06 0.89 0.04 0.07 0.89 0.04 0.06 0.90
Coprococcus 0.04 0.02 0.94 0.04 0.03 0.93 0.03 0.02 0.94 0.03 0.02 0.94 0.03 0.02 0.94
Dorea 0.30 0.01 0.69 0.35 0.00 0.65 0.32 0.01 0.68 0.33 0.01 0.67 0.30 0.01 0.69
Roseburia 0.00 0.10 0.89 0.00 0.10 0.89 0.01 0.10 0.89 0.01 0.10 0.89 0.01 0.10 0.89
Anaerofilum 0.05 0.17 0.78 0.04 0.16 0.80 0.05 0.15 0.80 0.05 0.16 0.80 0.05 0.14 0.81
Anaerotruncus 0.02 0.05 0.93 0.01 0.05 0.93 0.02 0.05 0.93 0.01 0.05 0.94 0.01 0.05 0.94
Butyricicoccus 0.03 0.06 0.91 0.03 0.06 0.91 0.03 0.05 0.92 0.03 0.06 0.91 0.03 0.06 0.91
Faecalibacterium 0.11 0.01 0.87 0.11 0.01 0.88 0.10 0.01 0.89 0.11 0.01 0.88 0.10 0.01 0.89
Oscillibacter 0.00 0.26 0.74 0.00 0.27 0.73 0.00 0.26 0.73 0.00 0.28 0.72 0.00 0.24 0.75
Ruminococcus 0.07 0.00 0.93 0.05 0.00 0.94 0.06 0.00 0.94 0.06 0.00 0.93 0.05 0.00 0.95
Subdoligranulum 0.08 0.01 0.92 0.06 0.01 0.93 0.06 0.01 0.93 0.06 0.01 0.92 0.07 0.01 0.92
Acidaminococcus 0.93 0.00 0.07 0.91 0.00 0.09 0.91 0.00 0.09 0.90 0.00 0.10 0.88 0.00 0.12
Allisonella 0.62 0.01 0.37 0.64 0.00 0.35 0.63 0.01 0.37 0.65 0.01 0.34 0.66 0.00 0.34
Dialister 0.00 0.04 0.96 0.00 0.05 0.95 0.00 0.05 0.95 0.00 0.04 0.96 0.00 0.04 0.96
Megamonas 0.00 0.55 0.45 0.00 0.48 0.52 0.00 0.49 0.51 0.00 0.49 0.51 0.00 0.49 0.51
Megasphaera 0.24 0.01 0.76 0.24 0.01 0.75 0.22 0.01 0.77 0.20 0.01 0.79 0.25 0.01 0.74
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Table A.2: Posterior probabilities with 5 starting values under sparse prior. Results are from
COMBO data at the genus level.
starting 1 starting 2 starting 3 starting 4 starting 5
set z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0
P. faecium 0.00 0.02 0.98 0.00 0.02 0.98 0.00 0.02 0.98 0.00 0.02 0.98 0.00 0.02 0.98
Veillonella 0.01 0.18 0.81 0.01 0.18 0.81 0.01 0.17 0.82 0.00 0.16 0.83 0.01 0.17 0.82
Catenibacterium 0.57 0.01 0.42 0.47 0.00 0.53 0.50 0.00 0.49 0.49 0.00 0.50 0.47 0.01 0.52
Coprobacillus 0.00 0.15 0.85 0.00 0.17 0.83 0.00 0.17 0.83 0.00 0.19 0.81 0.00 0.17 0.83
Holdemania 0.02 0.07 0.91 0.01 0.08 0.90 0.02 0.08 0.91 0.01 0.07 0.91 0.02 0.08 0.91
Solobacterium 0.04 0.15 0.82 0.03 0.17 0.80 0.03 0.16 0.80 0.03 0.16 0.81 0.04 0.17 0.79
Turicibacter 0.16 0.03 0.81 0.14 0.04 0.82 0.12 0.03 0.85 0.12 0.04 0.84 0.14 0.03 0.83
Parasutterella 0.01 0.03 0.97 0.01 0.02 0.97 0.00 0.02 0.97 0.00 0.02 0.98 0.00 0.02 0.98
Sutterella 0.01 0.03 0.96 0.01 0.02 0.97 0.00 0.03 0.97 0.00 0.03 0.97 0.00 0.03 0.97
Oxalobacter 0.02 0.16 0.82 0.02 0.18 0.81 0.02 0.16 0.81 0.02 0.18 0.80 0.02 0.16 0.82
A.1.2. Additional results on UK twin data
Table A.3: Posterior probabilities with 5 starting values under uniform prior. Results are from UK
twin data at the genus level.
starting 1 starting 2 starting 3 starting 4 starting 5
set z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0
Acidaminococcus 0.00 0.58 0.42 0.00 0.61 0.39 0.00 0.60 0.39 0.00 0.63 0.37 0.00 0.61 0.39
Actinomyces 0.90 0.00 0.10 0.88 0.00 0.12 0.89 0.00 0.11 0.89 0.00 0.11 0.90 0.00 0.10
Adlercreutzia 0.33 0.07 0.60 0.36 0.07 0.57 0.34 0.08 0.58 0.33 0.07 0.60 0.36 0.07 0.57
Aggregatibacter 0.03 0.58 0.39 0.03 0.59 0.39 0.02 0.62 0.36 0.03 0.57 0.40 0.02 0.62 0.37
Akkermansia 0.36 0.00 0.64 0.35 0.00 0.65 0.31 0.00 0.69 0.37 0.00 0.63 0.32 0.00 0.68
Alistipes 0.42 0.06 0.52 0.42 0.08 0.49 0.40 0.08 0.51 0.42 0.08 0.50 0.44 0.07 0.49
Anaerofustis 0.28 0.13 0.59 0.29 0.13 0.58 0.27 0.15 0.58 0.29 0.14 0.57 0.27 0.15 0.59
Anaerostipes 0.00 0.94 0.06 0.00 0.94 0.06 0.00 0.92 0.08 0.00 0.92 0.08 0.00 0.92 0.08
Anaerotruncus 0.31 0.11 0.58 0.30 0.13 0.56 0.30 0.11 0.59 0.30 0.11 0.59 0.31 0.12 0.57
Anaerovorax 0.67 0.03 0.30 0.67 0.03 0.30 0.65 0.03 0.32 0.65 0.04 0.32 0.62 0.03 0.35
Bacteroides 0.01 0.87 0.12 0.01 0.87 0.13 0.01 0.85 0.14 0.01 0.87 0.13 0.01 0.85 0.14
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Table A.3: Posterior probabilities with 5 starting values under uniform prior. Results are from UK
twin data at the genus level.
starting 1 starting 2 starting 3 starting 4 starting 5
set z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0
Bifidobacterium 0.00 1.00 0.00 0.00 1.00 0.00 0.00 1.00 0.00 0.00 1.00 0.00 0.00 1.00 0.00
Bilophila 0.25 0.03 0.73 0.22 0.03 0.75 0.25 0.03 0.73 0.23 0.02 0.74 0.22 0.03 0.75
Blautia 0.01 0.84 0.14 0.01 0.86 0.13 0.01 0.85 0.14 0.01 0.86 0.13 0.01 0.86 0.13
Bulleidia 0.65 0.02 0.33 0.69 0.02 0.29 0.67 0.01 0.32 0.65 0.02 0.33 0.69 0.02 0.29
Butyricimonas 0.10 0.03 0.87 0.11 0.02 0.87 0.10 0.02 0.87 0.10 0.02 0.88 0.10 0.02 0.87
Campylobacter 0.25 0.21 0.54 0.26 0.23 0.51 0.27 0.21 0.52 0.25 0.24 0.51 0.25 0.21 0.53
Catenibacterium 0.26 0.01 0.73 0.26 0.01 0.73 0.27 0.01 0.72 0.26 0.01 0.73 0.27 0.01 0.72
cc 115 0.22 0.04 0.74 0.22 0.04 0.74 0.22 0.04 0.74 0.23 0.05 0.72 0.23 0.04 0.73
Christensenella 0.01 0.86 0.14 0.00 0.83 0.16 0.01 0.81 0.19 0.00 0.83 0.17 0.00 0.82 0.17
Citrobacter 0.45 0.01 0.54 0.47 0.01 0.52 0.47 0.01 0.52 0.49 0.01 0.50 0.47 0.01 0.52
Clostridium 0.65 0.00 0.35 0.67 0.00 0.33 0.65 0.00 0.35 0.68 0.00 0.31 0.63 0.00 0.36
Collinsella 0.16 0.00 0.84 0.16 0.01 0.83 0.15 0.01 0.84 0.17 0.00 0.83 0.16 0.01 0.83
Coprobacillus 0.75 0.00 0.24 0.76 0.00 0.24 0.74 0.00 0.25 0.77 0.00 0.23 0.75 0.00 0.25
Coprococcus 0.11 0.52 0.37 0.11 0.48 0.41 0.11 0.49 0.40 0.10 0.53 0.37 0.10 0.50 0.40
Corynebacterium 0.11 0.49 0.40 0.12 0.47 0.41 0.11 0.48 0.41 0.13 0.44 0.43 0.10 0.49 0.41
Dehalobacterium 0.14 0.23 0.63 0.15 0.25 0.60 0.14 0.24 0.61 0.14 0.27 0.59 0.14 0.24 0.62
Desulfovibrio 0.27 0.00 0.73 0.29 0.00 0.71 0.31 0.00 0.69 0.29 0.00 0.71 0.27 0.00 0.73
Dialister 0.00 1.00 0.00 0.00 0.99 0.01 0.00 1.00 0.00 0.00 0.99 0.01 0.00 1.00 0.00
Dorea 0.37 0.15 0.48 0.34 0.17 0.50 0.35 0.17 0.48 0.36 0.15 0.49 0.35 0.15 0.50
Eggerthella 0.21 0.16 0.63 0.23 0.19 0.59 0.22 0.18 0.60 0.21 0.18 0.61 0.20 0.20 0.60
Enterococcus 0.25 0.07 0.67 0.26 0.08 0.65 0.26 0.08 0.66 0.25 0.08 0.66 0.26 0.08 0.66
Faecalibacterium 0.01 0.88 0.11 0.01 0.88 0.11 0.00 0.88 0.11 0.00 0.90 0.10 0.00 0.89 0.11
Fusobacterium 0.20 0.15 0.65 0.23 0.17 0.60 0.22 0.15 0.63 0.21 0.16 0.63 0.22 0.15 0.64
Haemophilus 0.09 0.06 0.85 0.10 0.09 0.81 0.12 0.07 0.81 0.10 0.07 0.83 0.10 0.06 0.84
Holdemania 0.59 0.02 0.39 0.61 0.02 0.37 0.62 0.02 0.36 0.62 0.01 0.37 0.63 0.02 0.35
Lachnobacterium 0.21 0.07 0.71 0.22 0.08 0.71 0.21 0.08 0.71 0.23 0.08 0.69 0.20 0.07 0.73
Lachnospira 0.76 0.00 0.24 0.76 0.01 0.23 0.73 0.00 0.27 0.75 0.00 0.25 0.74 0.01 0.26
Lactobacillus 0.98 0.00 0.02 0.98 0.00 0.02 0.97 0.00 0.03 0.98 0.00 0.02 0.98 0.00 0.02
Lactococcus 0.10 0.39 0.51 0.11 0.40 0.49 0.12 0.39 0.49 0.11 0.41 0.48 0.12 0.41 0.47
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Table A.3: Posterior probabilities with 5 starting values under uniform prior. Results are from UK
twin data at the genus level.
starting 1 starting 2 starting 3 starting 4 starting 5
set z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0
Megasphaera 0.17 0.09 0.73 0.17 0.11 0.72 0.16 0.11 0.73 0.18 0.10 0.72 0.16 0.12 0.72
Methanobrevibacter 0.50 0.00 0.50 0.51 0.00 0.49 0.52 0.00 0.48 0.50 0.00 0.50 0.53 0.00 0.47
Odoribacter 0.65 0.00 0.35 0.64 0.00 0.36 0.61 0.00 0.39 0.63 0.00 0.37 0.58 0.00 0.41
Oscillospira 0.29 0.21 0.50 0.30 0.19 0.51 0.31 0.22 0.48 0.31 0.21 0.49 0.31 0.21 0.48
Oxalobacter 0.05 0.14 0.81 0.05 0.16 0.78 0.06 0.16 0.78 0.05 0.15 0.80 0.05 0.15 0.80
Parabacteroides 0.00 0.65 0.34 0.00 0.68 0.31 0.00 0.68 0.31 0.00 0.68 0.31 0.00 0.71 0.29
Paraprevotella 0.02 0.01 0.98 0.02 0.02 0.96 0.02 0.02 0.96 0.03 0.01 0.96 0.02 0.02 0.97
P. faecium 0.02 0.00 0.98 0.03 0.00 0.97 0.02 0.00 0.98 0.02 0.00 0.98 0.03 0.00 0.96
Porphyromonas 0.43 0.04 0.53 0.44 0.04 0.52 0.42 0.05 0.53 0.43 0.04 0.53 0.42 0.05 0.53
Prevotella 0.01 0.01 0.99 0.02 0.01 0.97 0.01 0.00 0.99 0.01 0.01 0.98 0.01 0.00 0.98
Ralstonia 0.12 0.32 0.55 0.13 0.37 0.51 0.12 0.36 0.52 0.12 0.35 0.53 0.13 0.34 0.53
rc4-4 0.41 0.01 0.58 0.39 0.01 0.60 0.42 0.01 0.57 0.38 0.01 0.62 0.40 0.01 0.59
Roseburia 0.07 0.38 0.55 0.08 0.38 0.54 0.05 0.43 0.52 0.07 0.38 0.54 0.05 0.41 0.55
Rothia 0.34 0.10 0.56 0.36 0.10 0.54 0.34 0.12 0.55 0.35 0.10 0.56 0.33 0.12 0.55
Ruminococcus 0.50 0.08 0.42 0.53 0.08 0.39 0.52 0.08 0.40 0.54 0.07 0.40 0.52 0.07 0.41
Serratia 0.41 0.03 0.56 0.44 0.03 0.53 0.43 0.03 0.54 0.42 0.04 0.55 0.41 0.03 0.56
Slackia 0.52 0.01 0.48 0.52 0.01 0.47 0.56 0.01 0.43 0.52 0.01 0.47 0.55 0.01 0.45
SMB53 0.09 0.44 0.47 0.10 0.43 0.47 0.08 0.42 0.49 0.08 0.47 0.45 0.09 0.45 0.46
Streptococcus 0.98 0.00 0.02 0.98 0.00 0.02 0.99 0.00 0.01 0.98 0.00 0.02 0.99 0.00 0.01
Sutterella 0.00 0.74 0.26 0.00 0.72 0.27 0.00 0.70 0.30 0.00 0.71 0.28 0.00 0.67 0.33
Trabulsiella 0.95 0.00 0.05 0.95 0.00 0.05 0.93 0.00 0.07 0.94 0.00 0.06 0.94 0.00 0.06
Turicibacter 0.82 0.00 0.18 0.80 0.00 0.20 0.84 0.00 0.16 0.83 0.00 0.17 0.81 0.00 0.19
Veillonella 1.00 0.00 0.00 1.00 0.00 0.00 0.99 0.00 0.01 0.99 0.00 0.01 0.99 0.00 0.01
WAL 1855D 0.00 0.94 0.06 0.00 0.94 0.05 0.00 0.94 0.06 0.00 0.95 0.05 0.00 0.93 0.07
Eubacterium 0.00 0.34 0.66 0.00 0.36 0.64 0.00 0.41 0.59 0.00 0.34 0.65 0.00 0.39 0.61
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Table A.4: Posterior probabilities with 5 starting values under sparse prior. Results are from UK
twin data at the genus level.
starting 1 starting 2 starting 3 starting 4 starting 5
set z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0
Acidaminococcus 0.00 0.08 0.92 0.00 0.09 0.91 0.00 0.07 0.93 0.00 0.08 0.92 0.00 0.08 0.92
Actinomyces 0.70 0.00 0.30 0.68 0.00 0.32 0.75 0.00 0.24 0.69 0.00 0.31 0.73 0.00 0.27
Adlercreutzia 0.10 0.00 0.90 0.09 0.00 0.90 0.11 0.00 0.89 0.11 0.00 0.89 0.11 0.00 0.88
Aggregatibacter 0.00 0.18 0.82 0.00 0.17 0.83 0.00 0.16 0.84 0.00 0.19 0.81 0.00 0.16 0.84
Akkermansia 0.03 0.00 0.97 0.03 0.00 0.97 0.03 0.00 0.97 0.02 0.00 0.98 0.03 0.00 0.97
Alistipes 0.10 0.01 0.89 0.09 0.01 0.91 0.11 0.00 0.89 0.09 0.01 0.90 0.11 0.01 0.88
Anaerofustis 0.11 0.00 0.88 0.11 0.01 0.88 0.13 0.00 0.87 0.12 0.00 0.88 0.13 0.01 0.87
Anaerostipes 0.00 0.47 0.53 0.00 0.49 0.51 0.00 0.44 0.56 0.00 0.47 0.53 0.00 0.45 0.55
Anaerotruncus 0.07 0.01 0.92 0.09 0.00 0.91 0.08 0.00 0.92 0.07 0.00 0.92 0.08 0.00 0.92
Anaerovorax 0.46 0.00 0.54 0.43 0.00 0.57 0.45 0.00 0.55 0.49 0.00 0.51 0.46 0.00 0.54
Bacteroides 0.00 0.86 0.14 0.00 0.87 0.13 0.00 0.90 0.10 0.00 0.86 0.13 0.00 0.88 0.12
Bifidobacterium 0.00 1.00 0.00 0.00 1.00 0.00 0.00 1.00 0.00 0.00 1.00 0.00 0.00 1.00 0.00
Bilophila 0.01 0.00 0.99 0.01 0.00 0.99 0.01 0.00 0.99 0.01 0.00 0.99 0.00 0.00 0.99
Blautia 0.00 0.77 0.23 0.00 0.80 0.20 0.00 0.84 0.16 0.00 0.85 0.15 0.00 0.82 0.18
Bulleidia 0.30 0.00 0.70 0.33 0.00 0.67 0.30 0.00 0.70 0.32 0.00 0.68 0.32 0.00 0.68
Butyricimonas 0.01 0.00 0.99 0.01 0.00 0.99 0.01 0.00 0.99 0.00 0.00 1.00 0.01 0.00 0.99
Campylobacter 0.05 0.03 0.92 0.06 0.03 0.91 0.06 0.02 0.92 0.05 0.02 0.92 0.05 0.02 0.92
Catenibacterium 0.00 0.00 1.00 0.00 0.00 1.00 0.00 0.00 1.00 0.00 0.00 1.00 0.01 0.00 0.99
cc 115 0.05 0.00 0.95 0.07 0.00 0.93 0.05 0.00 0.95 0.08 0.00 0.92 0.06 0.00 0.94
Christensenella 0.00 0.22 0.77 0.00 0.23 0.76 0.00 0.15 0.85 0.00 0.19 0.81 0.00 0.19 0.81
Citrobacter 0.05 0.00 0.95 0.05 0.00 0.95 0.04 0.00 0.96 0.04 0.00 0.96 0.06 0.00 0.94
Clostridium 0.41 0.00 0.59 0.40 0.00 0.60 0.35 0.00 0.65 0.43 0.00 0.57 0.40 0.00 0.60
Collinsella 0.01 0.00 0.99 0.01 0.00 0.99 0.01 0.00 0.99 0.01 0.00 0.99 0.01 0.00 0.99
Coprobacillus 0.54 0.00 0.46 0.52 0.00 0.48 0.51 0.00 0.49 0.51 0.00 0.49 0.53 0.00 0.47
Coprococcus 0.03 0.11 0.86 0.04 0.10 0.86 0.05 0.09 0.86 0.03 0.08 0.89 0.04 0.09 0.87
Corynebacterium 0.02 0.12 0.86 0.02 0.13 0.85 0.02 0.10 0.88 0.02 0.12 0.86 0.02 0.10 0.88
Dehalobacterium 0.12 0.00 0.88 0.11 0.00 0.88 0.11 0.00 0.89 0.10 0.00 0.90 0.11 0.00 0.89
Desulfovibrio 0.00 0.00 1.00 0.01 0.00 0.99 0.00 0.00 1.00 0.01 0.00 0.99 0.01 0.00 0.99
Dialister 0.00 0.48 0.52 0.00 0.56 0.44 0.00 0.41 0.59 0.00 0.54 0.46 0.00 0.44 0.56
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Table A.4: Posterior probabilities with 5 starting values under sparse prior. Results are from UK
twin data at the genus level.
starting 1 starting 2 starting 3 starting 4 starting 5
set z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0
Dorea 0.08 0.03 0.88 0.08 0.04 0.88 0.08 0.03 0.89 0.09 0.03 0.88 0.09 0.03 0.89
Eggerthella 0.03 0.03 0.94 0.02 0.03 0.95 0.02 0.02 0.96 0.02 0.02 0.95 0.02 0.02 0.96
Enterococcus 0.02 0.00 0.97 0.02 0.01 0.97 0.03 0.01 0.97 0.02 0.01 0.98 0.02 0.00 0.97
Faecalibacterium 0.00 0.77 0.23 0.00 0.77 0.23 0.00 0.76 0.24 0.00 0.80 0.20 0.00 0.80 0.20
Fusobacterium 0.02 0.02 0.97 0.01 0.02 0.97 0.01 0.01 0.97 0.01 0.01 0.98 0.01 0.01 0.97
Haemophilus 0.00 0.02 0.98 0.00 0.02 0.98 0.00 0.01 0.99 0.00 0.01 0.99 0.00 0.01 0.98
Holdemania 0.16 0.00 0.84 0.18 0.00 0.82 0.11 0.00 0.89 0.18 0.00 0.82 0.14 0.00 0.86
Lachnobacterium 0.01 0.00 0.99 0.01 0.00 0.99 0.01 0.00 0.99 0.01 0.00 0.99 0.01 0.00 0.99
Lachnospira 0.44 0.00 0.56 0.40 0.00 0.60 0.43 0.00 0.57 0.39 0.00 0.61 0.44 0.00 0.56
Lactobacillus 0.77 0.00 0.23 0.78 0.00 0.22 0.74 0.00 0.26 0.77 0.00 0.23 0.76 0.00 0.24
Lactococcus 0.01 0.06 0.93 0.01 0.06 0.93 0.01 0.05 0.94 0.01 0.06 0.93 0.01 0.06 0.93
Megasphaera 0.00 0.01 0.99 0.00 0.01 0.99 0.00 0.00 0.99 0.00 0.01 0.99 0.00 0.01 0.99
Methanobrevibacter 0.20 0.00 0.80 0.20 0.00 0.80 0.22 0.00 0.78 0.16 0.00 0.84 0.19 0.00 0.81
Odoribacter 0.11 0.00 0.89 0.11 0.00 0.89 0.08 0.00 0.92 0.11 0.00 0.89 0.08 0.00 0.92
Oscillospira 0.08 0.02 0.90 0.10 0.01 0.89 0.09 0.01 0.90 0.09 0.02 0.89 0.08 0.02 0.90
Oxalobacter 0.00 0.00 1.00 0.00 0.00 0.99 0.00 0.00 1.00 0.00 0.00 1.00 0.01 0.00 0.99
Parabacteroides 0.00 0.07 0.93 0.00 0.07 0.93 0.00 0.04 0.96 0.00 0.06 0.94 0.00 0.06 0.94
Paraprevotella 0.00 0.00 1.00 0.00 0.00 1.00 0.00 0.00 1.00 0.00 0.00 1.00 0.00 0.00 1.00
P. faecium 0.00 0.00 1.00 0.00 0.00 1.00 0.00 0.00 1.00 0.00 0.00 1.00 0.00 0.00 1.00
Porphyromonas 0.21 0.00 0.79 0.22 0.00 0.78 0.22 0.00 0.78 0.19 0.00 0.81 0.21 0.00 0.79
Prevotella 0.00 0.00 1.00 0.00 0.00 1.00 0.00 0.00 1.00 0.00 0.00 1.00 0.00 0.00 1.00
Ralstonia 0.01 0.05 0.94 0.01 0.05 0.94 0.01 0.04 0.95 0.01 0.05 0.94 0.01 0.05 0.94
rc4-4 0.02 0.00 0.98 0.02 0.00 0.98 0.02 0.00 0.98 0.03 0.00 0.97 0.02 0.00 0.98
Roseburia 0.00 0.16 0.83 0.00 0.15 0.85 0.00 0.10 0.89 0.00 0.13 0.86 0.00 0.13 0.87
Rothia 0.03 0.03 0.93 0.03 0.04 0.92 0.03 0.03 0.94 0.02 0.04 0.94 0.04 0.04 0.93
Ruminococcus 0.28 0.00 0.71 0.29 0.01 0.70 0.33 0.00 0.66 0.28 0.01 0.72 0.29 0.01 0.71
Serratia 0.04 0.00 0.96 0.03 0.00 0.97 0.03 0.00 0.96 0.03 0.00 0.96 0.04 0.00 0.96
Slackia 0.12 0.00 0.88 0.11 0.00 0.89 0.12 0.00 0.88 0.11 0.00 0.89 0.12 0.00 0.88
SMB53 0.01 0.05 0.94 0.01 0.03 0.96 0.02 0.03 0.95 0.01 0.05 0.93 0.01 0.04 0.95
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Table A.4: Posterior probabilities with 5 starting values under sparse prior. Results are from UK
twin data at the genus level.
starting 1 starting 2 starting 3 starting 4 starting 5
set z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0
Streptococcus 0.85 0.00 0.15 0.87 0.00 0.13 0.87 0.00 0.13 0.86 0.00 0.14 0.86 0.00 0.14
Sutterella 0.00 0.13 0.87 0.00 0.15 0.85 0.00 0.12 0.88 0.00 0.14 0.86 0.00 0.09 0.91
Trabulsiella 0.92 0.00 0.08 0.93 0.00 0.07 0.94 0.00 0.06 0.94 0.00 0.06 0.92 0.00 0.08
Turicibacter 0.21 0.00 0.79 0.19 0.00 0.81 0.15 0.00 0.85 0.20 0.00 0.80 0.17 0.00 0.83
Veillonella 0.97 0.00 0.03 0.98 0.00 0.02 0.95 0.00 0.05 0.97 0.00 0.03 0.95 0.00 0.05
WAL 1855D 0.00 0.87 0.13 0.00 0.88 0.12 0.00 0.90 0.10 0.00 0.89 0.11 0.00 0.90 0.10
Eubacterium 0.00 0.01 0.99 0.00 0.01 0.99 0.00 0.00 1.00 0.00 0.00 1.00 0.00 0.00 1.00
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A.2. Chapter 3 - additional results on analysis of IBD data set
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Additional results on IBD data
Table A.5: Posterior probabilities with 5 starting points. Results are from genera level IBD data with
uniform prior.
starting 1 starting 2 starting 3 starting 4 starting 5
set z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0
Prevotella 0.01 0.90 0.09 0.01 0.91 0.08 0.01 0.90 0.09 0.01 0.91 0.08 0.01 0.90 0.09
Faecalibacterium 0.38 0.18 0.45 0.38 0.17 0.45 0.39 0.18 0.44 0.38 0.17 0.45 0.38 0.18 0.44
Eubacterium 0.15 0.45 0.41 0.16 0.43 0.41 0.15 0.44 0.41 0.16 0.42 0.41 0.16 0.43 0.41
Alistipes 0.17 0.39 0.44 0.17 0.38 0.45 0.16 0.39 0.45 0.16 0.39 0.44 0.17 0.39 0.44
Bacteroides 0.33 0.25 0.42 0.33 0.23 0.44 0.35 0.23 0.43 0.33 0.23 0.43 0.31 0.24 0.44
Odoribacter 0.07 0.58 0.35 0.08 0.57 0.36 0.07 0.57 0.36 0.08 0.56 0.35 0.08 0.55 0.38
Dorea 0.36 0.21 0.43 0.35 0.21 0.44 0.33 0.22 0.45 0.37 0.22 0.42 0.34 0.22 0.44
Ruminococcus 0.21 0.37 0.42 0.20 0.38 0.42 0.20 0.37 0.43 0.21 0.37 0.42 0.20 0.37 0.43
Parabacteroides 0.20 0.34 0.46 0.19 0.36 0.45 0.21 0.34 0.45 0.20 0.36 0.44 0.20 0.36 0.44
Akkermansia 0.10 0.52 0.38 0.10 0.53 0.38 0.09 0.52 0.39 0.10 0.52 0.38 0.09 0.53 0.38
Roseburia 0.07 0.58 0.35 0.08 0.57 0.35 0.08 0.57 0.35 0.08 0.57 0.35 0.07 0.57 0.36
Bilophila 0.29 0.25 0.46 0.29 0.25 0.46 0.29 0.24 0.48 0.29 0.24 0.47 0.28 0.26 0.46
Streptococcus 0.29 0.25 0.46 0.30 0.25 0.45 0.29 0.24 0.46 0.31 0.25 0.44 0.30 0.24 0.46
Coprococcus 0.24 0.31 0.45 0.23 0.32 0.45 0.24 0.31 0.45 0.24 0.31 0.45 0.25 0.30 0.45
Collinsella 0.18 0.37 0.45 0.17 0.39 0.44 0.17 0.38 0.44 0.19 0.37 0.44 0.17 0.36 0.46
Clostridium 0.27 0.27 0.45 0.28 0.28 0.43 0.27 0.27 0.47 0.28 0.27 0.45 0.28 0.27 0.45
Sutterella 0.44 0.11 0.45 0.45 0.11 0.45 0.46 0.10 0.44 0.45 0.09 0.45 0.46 0.10 0.44
Bifidobacterium 0.16 0.38 0.47 0.15 0.40 0.45 0.16 0.40 0.45 0.17 0.38 0.45 0.15 0.39 0.46
Anaerotruncus 0.26 0.30 0.43 0.25 0.31 0.44 0.26 0.29 0.45 0.26 0.30 0.44 0.26 0.31 0.43
Lactococcus 0.34 0.20 0.46 0.34 0.20 0.46 0.34 0.20 0.46 0.35 0.20 0.46 0.32 0.21 0.47
Gordonibacter 0.47 0.13 0.40 0.47 0.14 0.39 0.48 0.14 0.38 0.47 0.13 0.39 0.48 0.14 0.38
Eggerthella 0.58 0.08 0.34 0.60 0.07 0.33 0.58 0.07 0.34 0.58 0.07 0.35 0.59 0.07 0.34
Holdemania 0.34 0.21 0.45 0.34 0.23 0.43 0.32 0.22 0.46 0.33 0.22 0.45 0.33 0.22 0.45
Dialister 0.31 0.17 0.52 0.33 0.18 0.50 0.32 0.17 0.51 0.32 0.17 0.51 0.33 0.17 0.50
Haemophilus 0.33 0.19 0.48 0.35 0.20 0.45 0.33 0.18 0.49 0.34 0.18 0.49 0.33 0.19 0.48
Escherichia 0.80 0.01 0.19 0.76 0.01 0.22 0.80 0.01 0.19 0.78 0.01 0.21 0.79 0.02 0.20
Veillonella 0.57 0.06 0.37 0.60 0.06 0.34 0.59 0.07 0.35 0.56 0.06 0.37 0.59 0.07 0.35
Coprobacillus 0.32 0.22 0.46 0.32 0.21 0.47 0.31 0.21 0.47 0.33 0.20 0.47 0.33 0.21 0.46
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Table A.5: Posterior probabilities with 5 starting points. Results are from genera level IBD data with
uniform prior.
starting 1 starting 2 starting 3 starting 4 starting 5
set z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0
Anaerostipes 0.32 0.24 0.43 0.33 0.23 0.44 0.32 0.25 0.43 0.34 0.23 0.43 0.32 0.25 0.43
Rothia 0.57 0.08 0.35 0.58 0.07 0.35 0.57 0.08 0.35 0.59 0.08 0.33 0.57 0.07 0.35
Klebsiella 0.57 0.07 0.36 0.56 0.07 0.37 0.55 0.07 0.38 0.55 0.07 0.38 0.56 0.07 0.37
Table A.6: Posterior probabilities with 5 starting points. Results are from genera level IBD data with
sparse prior.
starting 1 starting 2 starting 3 starting 4 starting 5
set z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0
Prevotella 0.00 0.91 0.09 0.00 0.91 0.09 0.00 0.89 0.11 0.00 0.90 0.10 0.00 0.90 0.10
Faecalibacterium 0.11 0.03 0.87 0.10 0.03 0.87 0.11 0.03 0.86 0.10 0.03 0.87 0.11 0.03 0.86
Eubacterium 0.03 0.12 0.85 0.03 0.12 0.85 0.03 0.12 0.84 0.04 0.12 0.84 0.04 0.12 0.85
Alistipes 0.04 0.08 0.88 0.04 0.08 0.87 0.03 0.09 0.88 0.04 0.09 0.87 0.03 0.09 0.88
Bacteroides 0.09 0.05 0.86 0.09 0.05 0.86 0.09 0.04 0.87 0.09 0.04 0.87 0.08 0.05 0.87
Odoribacter 0.02 0.15 0.84 0.02 0.17 0.81 0.02 0.15 0.83 0.02 0.15 0.83 0.01 0.15 0.83
Dorea 0.09 0.04 0.87 0.09 0.04 0.87 0.09 0.04 0.87 0.08 0.04 0.87 0.09 0.04 0.86
Ruminococcus 0.05 0.10 0.86 0.05 0.10 0.85 0.05 0.10 0.85 0.05 0.10 0.85 0.05 0.10 0.85
Parabacteroides 0.04 0.06 0.89 0.05 0.07 0.89 0.04 0.08 0.88 0.05 0.07 0.89 0.05 0.07 0.88
Akkermansia 0.02 0.17 0.81 0.02 0.16 0.83 0.02 0.17 0.81 0.02 0.17 0.82 0.02 0.16 0.82
Roseburia 0.02 0.18 0.81 0.01 0.18 0.81 0.02 0.17 0.81 0.01 0.18 0.80 0.02 0.19 0.79
Bilophila 0.06 0.04 0.89 0.07 0.04 0.88 0.06 0.05 0.89 0.07 0.05 0.89 0.07 0.05 0.88
Streptococcus 0.11 0.03 0.86 0.12 0.03 0.85 0.12 0.03 0.85 0.12 0.03 0.84 0.11 0.03 0.86
Coprococcus 0.06 0.06 0.88 0.05 0.06 0.89 0.06 0.06 0.88 0.05 0.06 0.89 0.05 0.06 0.89
Collinsella 0.04 0.07 0.88 0.05 0.08 0.87 0.05 0.07 0.88 0.05 0.08 0.87 0.05 0.08 0.87
Clostridium 0.08 0.05 0.86 0.07 0.06 0.87 0.08 0.05 0.87 0.08 0.05 0.87 0.07 0.06 0.87
Sutterella 0.21 0.01 0.77 0.21 0.01 0.78 0.20 0.01 0.79 0.21 0.01 0.78 0.20 0.01 0.79
Bifidobacterium 0.04 0.06 0.90 0.04 0.07 0.89 0.04 0.06 0.90 0.04 0.06 0.90 0.04 0.06 0.90
Anaerotruncus 0.07 0.07 0.86 0.06 0.07 0.87 0.07 0.07 0.86 0.07 0.07 0.86 0.06 0.07 0.87
Lactococcus 0.11 0.03 0.87 0.10 0.03 0.87 0.10 0.03 0.88 0.09 0.03 0.88 0.10 0.03 0.88
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Table A.6: Posterior probabilities with 5 starting points. Results are from genera level IBD data with
sparse prior.
starting 1 starting 2 starting 3 starting 4 starting 5
set z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0 z+ z− z0
Gordonibacter 0.20 0.02 0.78 0.19 0.02 0.78 0.21 0.03 0.76 0.21 0.02 0.77 0.19 0.02 0.78
Eggerthella 0.25 0.01 0.74 0.25 0.01 0.74 0.25 0.01 0.74 0.26 0.01 0.73 0.26 0.01 0.73
Holdemania 0.09 0.04 0.87 0.08 0.04 0.88 0.08 0.05 0.88 0.09 0.04 0.87 0.08 0.04 0.87
Dialister 0.07 0.02 0.91 0.07 0.02 0.91 0.07 0.02 0.91 0.07 0.02 0.90 0.07 0.02 0.91
Haemophilus 0.11 0.02 0.87 0.12 0.02 0.86 0.11 0.02 0.87 0.11 0.02 0.86 0.11 0.02 0.87
Escherichia 0.59 0.00 0.41 0.59 0.00 0.41 0.59 0.00 0.41 0.55 0.00 0.45 0.57 0.00 0.43
Veillonella 0.24 0.01 0.75 0.23 0.01 0.77 0.22 0.01 0.77 0.23 0.01 0.76 0.24 0.01 0.75
Coprobacillus 0.11 0.03 0.86 0.11 0.03 0.86 0.11 0.03 0.86 0.11 0.03 0.86 0.11 0.03 0.86
Anaerostipes 0.13 0.04 0.83 0.12 0.04 0.84 0.12 0.04 0.84 0.12 0.04 0.84 0.12 0.04 0.84
Rothia 0.27 0.01 0.73 0.29 0.01 0.70 0.29 0.01 0.70 0.29 0.01 0.71 0.29 0.01 0.70
Klebsiella 0.31 0.01 0.68 0.28 0.01 0.71 0.31 0.01 0.68 0.34 0.01 0.65 0.32 0.01 0.68
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APPENDIX B
ASSUMPTIONS AND DERIVATION OF INDIRECT EFFECT
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B.1. Notation and assumptions in Chapter 4
The proposed Bayesian balance mediation model is given by
xi ∼ Multinomial(ni,pi) (B.1)
pi = φ
−1(µ0)⊕ ati ⊕Ui (B.2)
yi|z = az + cz · ti + bz ·Bzi + ezi (B.3)
In this model, only xi, ti, yi are observed variables. As the mediator Bziis a linear function of log pi
for a fixed indicator vector z, we use log pi in stating the assumptions. For a given indicator z
we can replace log pi with Bzi in these assumptions and the resulting statements still hold. Using
potential outcome framework, we define pi(t) as the potential outcome for the relative abundance
under Ti = t; yi(t, log p) is the potential outcome under Ti = t,pi = p. The actual latent variable
pi = pi(ti) and observed outcome is expressed as yi = yi(ti,pi). In this notation, Ti is the random
treatment and pi is the random relative abundance vector for subject i.
The assumptions required to derive the mediation effect (Lemma 1) are given as follows:
0 < P (Ti = t) < 1 (B.4)
0 < P (pi = p|Ti = t) < 1 (B.5)
{yi(t′, log p),pi(t)} ⊥⊥ Ti (B.6)
yi(t
′, log p) ⊥⊥ pi(t)|Ti (B.7)
No interaction between Ti and pi (B.8)
No interference among subjects (B.9)
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B.2. Proof of Lemma 1 in Chapter 4
Let bal(z, ·) be the balance index from a compositional vector and a fixed index vector z. Rewriting
Equations (B.2) -(B.3) in terms of bal(z, ·) and potential outcomes, we get
bal(z,pi(Ti)) = bal(z, φ
−1(µ0)) + Ti × bal(z,a) + bal(z,Ui(Ti)) (B.10)
yi(Ti, log pi(Ti)) = az + cz × Ti + bz × bal(z,pi(Ti)) + ezi(Ti, log pi(Ti)). (B.11)
Assumption (B.6) implies logUi(ti) ⊥⊥ Ti and bal(z,Ui(ti)) ⊥⊥ Ti with a fixed z. As a result,
E (bal(z,Ui(Ti))|Ti = ti) = E (bal(z,Ui(ti))) = 0 (B.12)
which leads to
E (bal(z,pi)|Ti) = bal(z, φ−1(µ0)) + Ti × bal(z,a) (B.13)
Assumption (B.7) implies ezi(ti, log pi) ⊥⊥ balz (pi(Ti)) |Ti = ti and leads to
E (ezi(Ti, log pi(Ti)|Ti = ti, log pi(Ti) = log pi) = E (ezi(Ti, log pi)|Ti = ti) . (B.14)
Under the assumption (B.6), the equation can be further simplified as E (ezi(ti, log pi)) = 0 and
applying this to Equation (B.11), we have
E (yi| log pi, Ti) = az + cz × Ti + bz × bal(z,pi) = E (yi|bal(z,pi), Ti) (B.15)
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Based on these assumptions, the causal direct effect can be derived as
ζ(τ) =Eyi(t, log pi(τ ))− Eyi(t0, log pi(τ ))
=
∫
[E(yi(t, log p)| log pi(τ ) = log p) −
E(yi(t0, log p)| log pi(τ ) = log p)] dFlog pi(τ)(log p)
=
∫
[E(yi(t, log p)| log pi(τ ) = log p, Ti = τ)−
E(yi(t0, log p)| log pi(τ ) = log p, Ti = τ)] dFlog pi(τ)(log p)
=
∫
[E(yi(t, log p)|Ti = τ)− E(yi(t0, log p)|Ti = τ)] dFlog pi(τ)(log p)
=
∫
[E(yi(t, log p)|Ti = t)− E(yi(t0, log p)|Ti = t0)] dFlog pi|Ti=τ (log p)
=
∫
[E(yi(t, log p)| log pi(t) = log p, Ti = t)−
E(yi(t0, log p)|, log pi(t0) = log p, Ti = t0)] dFlog pi|Ti=τ (log p)
=
∫
[E(yi| log pi(t) = log p, Ti = t)−
E(yi| log pi(t0) = log p, Ti = t0)] dFlog pi|Ti=τ (log p)
=
∫
cz × (t− t0)dFlog pi|Ti=τ (log p)
= cz × (t− t0)
where Fv1 and Fv1|v2 are the cumulative distribution functions of v1 and v1 conditioning on the value
of v2
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We can prove that the indirect effect, i.e., the mediation effect in a similar fashion.
δ(τ) =Eyi(τ, log pi(t))− Eyi(τ, log pi(t0))
=
∫
E(yi(τ, log p)|Ti = τ, log pi(t) = logp)dFlog pi(t)(log p)−
E(yi(τ, log p)|Ti = τ, log pi(t0) = logp)dFlog pi(t0)(log p)
=
∫
E(yi(t, log p)|Ti = τ, log pi(t) = log p)dFlog pi(t)(log p)−
E(yi(t0, log p)|Ti = τ, log pi(t0) = log p)dFlog pi(t0)(log p)
=
∫
E(yi(t, log p)|Ti = t, log pi(t) = log p)dFlog pi(t)(log p)−
E(yi(t0, log p)|Ti = t0, log pi(t0) = logp)dFlog pi(t0)(log p)
=
∫
E(yi|Ti = t, log pi(t) = log p)dFlog pi(t)(log p)−
E(yi|Ti = t0, log pi(t0) = logp)dFlog pi(t0)(log p)
=
∫
(az + cz × t+ bz × bal(z,pi(t)))dFlog pi(t)(log p)−
(az + cz × t0 + bz × bal(z,pi(t0)))dFlog pi(t0)(log p)
=
∫
bz × bal(z,pi(t))dFbal(z,pi(t)) −
∫
bz × bal(z,pi(t0))dFbal(z,pi(t0))
=bz × [E (bal(z,pi)|Ti = t)− E (bal(z,pi)|Ti = t0)]
=bz × (t− t0)× bal(z, a)
In two group analysis where Ti only has two values 0, 1, the perturbation vector is expressed as
φ−1(µ1 − µ0). The mediation effect is simplified as bz × bal(z, φ−1(µ1 − µ0)).
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